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RELATIVE CONTRIBUTIONS OF THE STRINGENT RESPONSE MEDIATORS 
(p)ppGpp AND DksA TO HAEMOPHILUS DUCREYI VIRULENCE IN HUMANS 
 
Haemophilus ducreyi causes chancroid, a sexually transmitted genital ulcerative 
disease that facilitates the transmission of HIV-1. H. ducreyi also causes non-sexually 
transmitted cutaneous ulcers in children in tropical regions. During human infection, H. 
ducreyi is subject to a variety of stresses. The stringent response is a bacterial stress 
response system induced by nutrient limiting conditions and mediated by guanosine tetra- 
and pentaphosphate [(p)ppGpp] and the transcriptional regulator DksA. (p)ppGpp and 
DksA jointly interact with RNA polymerase to regulate genes critical for bacterial 
survival. We hypothesized that the stringent response is required for H. ducreyi virulence 
in humans. A ΔrelAΔspoT mutant, which is unable to synthesize (p)ppGpp, was partially 
attenuated for abscess formation in human volunteers. Loss of (p)ppGpp increased 
bacterial resistance to phagocytosis and stationary phase survival; however, the mutant 
was more sensitive to oxidative stress. A ΔdksA mutant was also partially attenuated in 
humans. The ΔdksA mutant behaved like the (p)ppGpp mutant in stationary phase 
survival and sensitivity to oxidative stress, but exhibited decreased resistance to 
phagocytosis. Both mutants had decreased adherence to fibroblasts, but the mechanisms 
underlying the adherence defect were distinct. To better understand the roles of (p)ppGpp 
and DksA in regulating gene expression, we performed transcriptome analysis of the 
parent and mutant strains. (p)ppGpp and DksA deficiency resulted in dysregulation of 
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multiple genes including several known virulence determinants. At stationary phase, 
(p)ppGpp and DksA targets were not identical but significantly overlapped; as the 
mutants were phenotypically distinct, this finding underscores both the unique and joint 
roles DksA and (p)ppGpp play in regulation of H. ducreyi virulence. We conclude that 
(p)ppGpp and DksA play significant roles in H. ducreyi pathogenesis. This is the first 
study to show that the stringent response has a direct role in the ability of a bacterial 
pathogen to cause disease in humans.  
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Chapter I: 
 
Literature Review 
 
 
Section I: 
Haemophilus ducreyi and Ulcerative Disease 
 
Haemophilus ducreyi 
Haemophilus ducreyi is a gram-negative coccobacillus belonging to the 
Pasteurellaceae family in the gammaproteobacteria class. Due to its requirement for 
hemin, H. ducreyi was originally placed within the genus Haemophilus. Compared to 
other members of this group, H. ducreyi is genetically unique. H. ducreyi lacks many of 
the genes involved in fermentation of carbohydrates but possesses genes encoding 
menaquinones not commonly found in the true Haemophilus group (1). H. ducreyi is 
most closely related to Actinobacillus pleuropneumoniae, a porcine respiratory pathogen, 
and ribosomal RNA analysis reclassified H. ducreyi in the Actinobacillus genus (2-4). 
This cluster, which also includes Mannheimia haemolytica, forms a distinct lineage from 
the other Pasteurellaceae (2).  
Overall, H. ducreyi isolates exhibit a high degree of genetic homology (5). Based 
on differences in the migration of LOS, antigenicity, and in vitro growth characteristics, 
two classes of H. ducreyi clinical isolates have been defined (6, 7). Evidence suggests 
that these classes are still diverging. Recombination has introduced variant alleles that are 
 
 
2 
specific to each representative class. lspA2, ncaA, and dsrA alleles are different between 
the Class I and Class II strains (8). These genes produce proteins, which directly interact 
with the host and are likely exposed to more selective pressure than genes whose 
products are cytosolic. Analysis showed that the sequence of these genes alone can be 
used to distinguish between these two classes (8). 
H. ducreyi is the causative agent of chancroid, a sexually transmitted genital 
ulcerative disease. Augusto Ducrey was the first person to identify the causative agent of 
chancroid in 1889 through a series of repetitive autoinoculation experiments (9). The 
organism was later named in his honor. However, H. ducreyi was not successfully 
isolated until 1900 when Bezancon and his group used purified bacteria to inoculate 
human volunteers (10). 
 
Chancroid 
Chancroid was first identified as a disease clinically distinct from syphilis in 1852 
by Leon Bassereau (11). While syphilis, another ulcerative disease, causes hard ulcers, 
soft ulcers characterize chancroid. Papules develop on the genitals three to seven days 
after contact with an infected individual. The papules progress quickly into pustules that 
rupture into characteristic chancroidal ulcers. These ulcers often have ragged edges and a 
slightly rounded shape. The ulcer base is often covered by a necrotic, purulent exudate. In 
many cases, the infection progresses to include regional lymphadenopathy and bubo 
formation (12). H. ducreyi has never been reported to disseminate throughout the body 
and cause systemic infection. H. ducreyi grows best between 33°C and 35°C and likely 
cannot tolerate normal systemic temperatures (13). Lesions found outside of the genital 
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region or initial site of infection in a chancroid infected individual are often the result of 
autoinoculation.  
Diagnosis requires identification of the bacterium on rich culture medium that is 
not widely available. Furthermore, due to lack of appropriate culture conditions, H. 
ducreyi cannot always be recovered from patients’ lesions. Multiplex PCR is the most 
accurate test for diagnosis of H. ducreyi. It has a sensitivity of 95 to 98%, compared to 
the 75% sensitivity seen in culture-based diagnosis. A review of studies summarizing the 
prevalence of H. ducreyi in patients with GUD attending STI clinics showed that H. 
ducreyi is identified in 19.6% of GUD cases in endemic regions (14). Thus H. ducreyi is 
still a common cause of GUD. 
Current CDC guidelines for treatment of chancroid include one of the following 
therapies: 1 oral dose of 1g Azithromycin; 250 mg of Ceftriaxone delivered 
intramuscularly; 500 mg oral Erythromycin given 3 times a day for 7 days; or 500 mg 
Ciprofloxacin given twice a day for 3 days.  
Chancroid is an important disease because it facilitates acquisition of HIV-1. In 
fact, GUD is estimated to increase risk of HIV acquisition 25 fold (15). H. ducreyi 
infection induces an immune response that increases the number of CD4 positive T-cells 
and macrophages in the ulcerative region (16). CD4 positive cells are the primary targets 
for HIV infection. Compared to peripheral blood T cells and monocytes, lesional CD4 
cells have increased expression of CCR5, and lesional macrophages have increased 
expression CCR5 and CXCR4, important co-receptors for HIV entry into CD4 positive 
cells (17). H. ducreyi also disrupts mucosal integrity, which increases the opportunity for 
HIV-1 acquisition. Chancroidal ulcers in HIV-1 positive patients heal slowly and poorly 
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compared to seronegative patients (18). HIV-1 infection is associated with an increased 
number of ulcers during H. ducreyi infection (19). Thus, the interaction between HIV-1 
and H. ducreyi acquisition has global significance.  
Patients infected with HIV and GUD have increased plasma HIV RNA levels 
(20). Furthermore, treatment of GUD reduces viral loads (21). In early stages of disease, 
no increase in viral loads was found in HIV-positive volunteers, who were 
experimentally infected with H. ducreyi (22). Together, this indicates that untreated GUD 
in the ulcerative stage results in increased HIV virion pools in the plasma and urogenital 
compartments, which increases the probability of transmission.  
Due to an emphasis on syndromic management of genital ulcers in resource poor 
countries, the actual prevalence of chancroid is now unknown. The last estimate of 
chancroid prevalence by the WHO in 1995 was approximately 7 million cases per year 
worldwide (14). Chancroid prevalence appears to have substantially declined in resource-
poor countries and Europe; nucleic acid amplification tests estimate that chancroid 
currently accounts for less than 1% of genital ulcers (23). Surveillance studies in southern 
Africa, however, suggest that chancroid remains an important cause of GUD in Lesotho, 
Madagascar, and Malawi (23).  
Chancroid is rare in the United States and other industrialized nations but is 
endemic in resource poor countries. In order for chancroid to remain in a population, it 
has to be maintained in a population with a high sex-partner change rate. Thus, 
commercial sex workers allow for the maintenance of the disease in endemic areas. 
Targeting this reservoir of infection is thought to have caused an overall reduction in 
chancroid transmission. In fact, syndromic management and presumptive treatment of 
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high-risk populations worldwide have resulted in a substantial decline in chancroid and 
other sexually transmitted infections. Chancroid, however, remains endemic in Africa, 
Asia, and Latin America.  
 
Cutaneous Ulcers 
Although non-sexually transmitted cutaneous ulcers in children in the South 
Pacific islands and equatorial Africa are usually attributed to Treponema palladium 
subspecies pertenue, recent studies performed as part of a World Health Organization–
directed yaws eradication campaign suggest that H. ducreyi is a major cause of this 
syndrome. The first case of cutaneous ulceration caused by H. ducreyi was reported in an 
adult from Fiji in 1989 (24). Subsequent cases of cutaneous ulcers in children due to H. 
ducreyi were reported from a wide range of the South Pacific islands (25-27). In three 
recent, large, cross-sectional community surveys in Papua New Guinea, the Solomon 
Islands, and Ghana, the prevalence of skin ulcers was between 2 and 4%. H. ducreyi 
DNA is detected in 60, 32, and 10% of lesions while T. pallidum DNA is detected in only 
34, 0 and 0% (28-30). While the mode of transmission is unknown, CUD appears to be 
non-sexually transmitted. Considering the global prevalence of yaws, an estimated 2.5 
million cases, extragenital lesions resulting from H. ducreyi infection may be much more 
common than was previously recognized. Thus, understanding the pathogenesis of H. 
ducreyi remains important from the point of view of public health. 
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Antibiotic Resistance and Haemophilus ducreyi 
Controlling curable diseases such as chancroid is vital to minimizing HIV-1 
transmission. Due to syndromic management, there is no current information about 
antibiotic resistance in H. ducreyi (14). Circulating H. ducreyi strains are thought to be 
universally susceptible to quinolones, macrolides, and ceftriaxone. However, H. ducreyi 
has a tendency to acquire antibiotic resistance factors. Several isolates of H. ducreyi  have 
already been shown to be resistant to current or former lines of therapy (31). 
Chromosomal-mediated resistance has been described for trimethoprim, penicillin, and 
fluoroquinolones (32-34). Increasing MICs of ciprofloxacin and erythromycin have also 
been detected (34). Overall, this emphasizes the necessity of monitoring antimicrobial 
resistance of H. ducreyi strains. 
The New Delhi metallo-beta-lactamase-1 (NDM-1), which confers resistance to 
quinolones and ceftriaxone, has been detected across the globe within the 
Enterobacteriaceae (35). If H. ducreyi acquires quinolones and ceftriaxone resistance 
from the NDM-1 plasmid, only macrolides will be available for treatment. Standard 
antibiotic treatment has been used to manage chancroid in the past, however, the potential 
for multidrug resistance makes understanding how H. ducreyi survives in vivo of the 
upmost importance.   
 
Models of Chancroid Infection 
In order to study H. ducreyi pathogenesis, the Spinola laboratory developed a 
human infection model (36). The human infection model very closely simulates early 
stages of natural infection. In the human challenge model, volunteers are inoculated with 
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H. ducreyi 35000HP and isogenic mutants. The Class I Strain 35000, originally isolated 
from a patient with chancroid, was then human passaged to make H. ducreyi 35000HP 
(Human Passaged) (36, 37). The bacteria are delivered into the epidermis and dermis of 
the upper arm through wounds made by the tines of an allergy-testing device. The model 
allows us to study H. ducreyi as it faces natural in vivo stresses because H. ducreyi is in 
its natural human host. 
Phylogenetic analysis of cutaneous ulcer strains show that they are highly related 
to 35000HP (38). Data from our lab further demonstrates that CUD strains likely recently 
emerged from Class I strains (39). Overall, this suggests that the human inoculation 
model is relevant to the study of both chancroid and cutaneous ulcers. 
Human infection models have been used to understand pathogenesis and the 
immune response to pathogens to test vaccines (40). Human experimental models allow 
us to define virulence factors of human pathogens in their natural settings. H. ducreyi is 
one of the few bacterial pathogens for which pathogenesis can be studied in humans. 
Human challenges have been done for several pathogenic bacterial species, including but 
not limited to Streptococcus pneumoniae, enterotoxigenic E. coli, and enteropathogenic 
E. coli (41-43). These models were used or developed for testing of vaccines or vaccine 
components. Human inoculation experiments with Helicobacter pylori were stopped for 
reasons including lack of need for vaccines and lack of a clear strategy for vaccine 
development in the United States; and potential for risk to volunteer – unsuccessful 
eradication of bacteria after trial (42). The usefulness of human infection models for 
understanding bacterial pathogenesis in vivo allows for the maintenance of studies whose 
focus is not vaccine development. 
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 A temperature-dependent rabbit model does exist for H. ducreyi. In this model, 
rabbits are inoculated intradermally with 105 CFU of bacteria. When rabbits are housed at 
normal room temperature (23°C), they do not form lesions with this inoculum size. When 
rabbits are housed at 15-17°C, necrotic lesions form at the site of inoculation (44). A 
porcine model, in which pigs are inoculated in the ears using an allergy testing device 
similar to what is used in the human model, has also been established for chancroid (45). 
Finally, a macaque model of infection exists for H. ducreyi. Bacteria are injected into the 
foreskin of male macaques and the ulcers that are formed closely resemble those seen in 
humans (46). Female macaques, however, do not develop lesions at all and thus this 
model is gender limited. 
These models allow study of the pathogen to the ulcerative stage of disease, 
which is impossible in our human model. However, there are also limitations of these 
models. In all 3 animal models, animals develop serum antibodies to H. ducreyi. In 
natural and experimental infection, however, antibodies do not develop in early disease 
(47). Additionally, rabbits develop protection from secondary challenge which does not 
happen in natural or experimental infection (48). A much larger inoculum is necessary for 
infection in the animal models (104-7 CFU) versus the human challenge model (101-2 
CFU) likely because H. ducreyi is not a natural zoonotic pathogen (12). Lastly, a major 
problem with these models is that they are all clearance models; H. ducreyi is rapidly 
cleared from the animals making them unsuitable for the study of disease progression. In 
contrast, H. ducreyi replicates to a range of 104-6 CFU in experimental pustules of human 
volunteers (49) .  
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Host – Haemophilus ducreyi Interactions 
Experimental infection of H. ducreyi in humans mimics the time course of natural 
infection. After human experimental inoculation, fibrin and collagen are deposited in the 
wounds. Polymorphonuclear neutrophils and macrophages infiltrate the wounds at the 
site of infection thereafter (50). Within 48 hours, PMNs form an abscess at the site of 
infection that ultimately forms an ulcer within 7 days in the epidermis. Below the 
abscess, myeloid dendritic cells, CD4 and CD8 T cells and activated natural killer cells 
infiltrate the dermis. H. ducreyi is found within the abscess and within the dermis in 
pustules where it associates with fibrin, collagen, PMNs, and macrophages. During 
natural infection, H. ducreyi also colocalizes with fibrin and PMNs (51). Importantly, H. 
ducreyi is not found within phagocytes at the site of infection. 
Pustules caused by H. ducreyi contain several cell types. The majority of the 
pustule is comprised of PMNs; however macrophages, T-cells, dendritic cells and some B 
cells can also be found in the lesion (12, 50). Furthermore, collagen and fibrin deposition 
at the site of infection forms scaffolding, which ultimately supports pustule formation 
(12, 50). A macrophage collar forms at the base of the abscess (12, 50).  
In both natural and experimental infection, H. ducreyi associates with both PMNs 
and macrophages, but resists phagocytic uptake (12, 50, 52). Dendritic cells, however, do 
phagocytize H. ducreyi. The dendritic cells become partially activated, which stimulates 
the immune response (53, 54). CD4+ memory cells are recruited in naive volunteers to 
the site of infection, indicating a delayed-type hypersensitivity reaction, even in naïve 
volunteers (12, 55). The CD4+ memory cells produce IFN-gamma and IL-10. IL-10 is 
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thought to inhibit phagocytic activity, which prevents effective clearance of H. ducreyi 
(12, 53). 
In experimental infection, some volunteers repeatedly resolve infection 
(resolvers) while others repeatedly form pustules (pustule formers) (47). Pustule 
formation in individuals is dependent on both the host immune response and gender (47, 
56). Subsequently, interest in identifying the underlying differences between pustule 
formers and resolvers has deepened. Microarray analysis indicated that challenge with H. 
ducreyi results in distinct immune response between pustule formers and resolvers (53, 
56). Pustule formers have a mixed hyper inflammatory and regulatory transcriptional 
profile while resolvers exclusively expressed differentially regulated unique transcripts 
that should promote only a Th1 response or allow for expansion of Th17 cells (53). 
Recently, our lab conducted a study to determine if the skin microbiome dictated 
the outcome of experimental infection in volunteers. We did identify some potentially 
protective species (species associated with resolvers) and some potentially deleterious 
species (associated with pustule formation). Overall, after exposure to H. ducreyi, the 
microbiomes of sites on pustule formers were more similar to one another while sites on 
resolved persons were more dissimilar (van Rensburg, submitted). Thus, although the 
microbiome may exert some effect, the final outcome of the volunteers is still largely 
driven by host factors. 
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Section II: 
Haemophilus ducreyi Virulence 
 
 
Virulence Determinants of H. ducreyi 
The experimental human inoculation model has revealed genes critical for 
virulence of H. ducreyi. Not including this study, to date 32 isogenic mutants have been 
tested in the human challenge model. 10 mutants were fully attenuated (absolutely 
required for pustule formation) and 6 were partially attenuated. The remaining mutants 
encode genes that do not contribute to virulence; thus, the following discussion is largely 
limited to mutants found fully or partially attenuated in the human challenge model of H. 
ducreyi infection. 
Many of the known virulence factors of H. ducreyi are located in the outer 
membrane. For example, PAL is an OMP thought to play a critical role in stabilization of 
the membrane (57). In addition to decreased pustule formation rates, loss of PAL was 
associated with increased sensitivity to antibiotics, suggesting that the pal mutant exhibits 
an unstable outer membrane (12).  
The TonB dependent hemoglobin receptor HgbA is another OMP required for 
virulence (58). HgbA binds to hemoglobin, which is the sole heme source required for H. 
ducreyi infection in vivo (59). Loss of HgbA likely results in heme starvation, even when 
hemoglobin is readily available. Two additional TonB dependent heme receptors have 
been identified in H. ducreyi, TdhA and TdX. A tdX tdhA double mutant is fully 
virulence in the human model indicating that these receptors are likely dispensable in 
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vivo (59). This suggests that expression of HgbA is critical for heme acquisition in H. 
ducreyi.  
H. ducreyi also contains homologues of genes required for synthesis of 
enterobacterial common antigen (ECA). ECA is an outer membrane glycolipid 
commonly found on lipopolysaccharide (LPS) O-antigen or in capsule of Gram-negative 
enterobacterial species. The first enzyme in the ECA synthesis pathway, WecA, transfers 
N-acetylglucosamine to undecaprenyl-P. Although H. ducreyi does not express O-antigen 
or capsule, the wecA mutant was partially attenuated (60). This suggests that 
H. ducreyi may express a putative ECA-like glycoconjugate that is required for infection.  
Phagocytosis is a critical element of the innate immune response that enables 
pathogens to be rapidly contained and cleared. Although H. ducreyi colocalizes with 
polymorphonuclear leukocytes and macrophages, it evades phagocytosis. Evasion results 
from secretion of two large secreted proteins, LspA1 and LspA2. The two proteins are 
secreted by LspB; the lspB mutant was attenuated in the rabbit model of infection 
indicating that the ability to secrete LspA1 and LspA2 is necessary for virulence (61). 
LspA2 and LspA1 suppress Src family protein tyrosine kinase activity, which ultimately 
inhibits phagocytosis (62, 63). Furthermore, LspA1 was found to bind the C-terminus of 
Src kinase, which stimulates Src’s catalytic activity inhibiting Src activity (64). The 
lspA1 lspA2 double mutant is fully attenuated in both the rabbit and human models of 
infection (65, 66). Taken together, these studies suggest that expression of LspA1 and 
LspA2 allow H. ducreyi to resist phagocytosis. 
To combat bacteria, the innate immune system also produces APs whose purpose 
is to kill bacteria, which they are thought to do by primarily disrupting membrane 
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integrity. Bacteria have evolved multiple resistance strategies to avoid AP-mediated 
killing. One mechanism is the sensitive-to-antimicrobial-peptides (Sap) uptake 
transporters. SapA, the periplasmic binding protein, binds the AP and brings it to the 
periplasmic membrane. The SapBC proteins, which encode the periplasmic permease 
complex, translocate the APs into the cytoplasm. The APs are subsequently degraded by 
cytoplasmic peptidase. In H. ducreyi, a sapA mutant is partially attenuated for virulence 
while a sapBC mutant is fully attenuated (67, 68). Additionally, the sapA mutant is less 
susceptible to APs than the sapBC mutant. Taken together, these data suggest that the 
transport machinery remains active in the sapA mutant and thus, may still confer partial 
resistance to antimicrobial peptides.  
The H. ducreyi genome contains a large operon which has high homology to the 
tight adhesin (tad) operon of Aggregatibacter actinomycetemcomitans (69). Components 
of this operon, which is homologous to type IV secretion system NTPases, have been 
well characterized in the human challenge model. The three fimbriae-like proteins, Flp1-
3, are required for pustule formation (70). These proteins mediate adherence to human 
foreskin fibroblasts and microcolony formation in vitro. The Flp proteins are transported 
to the outer membrane by the Tad proteins, including TadA. TadA encodes an ATPase 
that is required for fibril production in A. actinomycetemcomitan (71). The tadA mutant is 
also fully attenuated in humans (72). Taken together, these results indicate that the ability 
to express the Flp proteins on the outer membrane is critical for pathogenesis.  
During experimental infection, H. ducreyi associates with fibrin and collagen in 
the papular and pustular stages and fibrin in the ulcerative stage (51, 73). In vitro studies 
show that H. ducreyi binds extracellular matrix proteins fibronectin, laminin, and type I 
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and III collagen (74). The necessary for collagen adhesion protein A, NcaA, as its name 
implies, is required for collagen binding in vitro. Expression of ncaA was absolutely 
required for pustule formation in humans, highlighting the additional importance of 
collagen binding in vivo (75).  
Resistance to serum-mediated killing is an important virulence mechanism for H. 
ducreyi. The outer membrane ducreyi serum resistance A (DsrA) protein has been 
identified as the primary mediator of serum resistance (76). DsrA functions by blocking 
binding of IGM, which is critical for activating the classical complement pathway (77). 
DltA, the ducreyi lectin A protein, provides partial serum resistance for H. ducreyi (78). 
Similar to the dsrA mutant, the dltA mutant is more susceptible to serum mediated-killing 
than the parent strain. Unlike the dsrA mutant, however, the dltA mutant is only partially 
attenuated in the human challenge model underscoring the fact that DsrA is the primary 
mediator of serum resistance in H. ducreyi (79). 
An fgbA mutant was partially attenuated in the human challenge model suggesting 
that fibrinogen binding plays a role in vivo (80). The gene encoding FgbA was originally 
identified using SCOTS to identify genes preferentially expressed in experimental 
pustules (73). The gene product was subsequently identified in a ligand blot assay with 
denatured proteins as a fibrinogen binding protein. However, recently, fibrinogen was 
shown to interact specifically and in a dose-dependent manner with DsrA at the surface 
of viable H. ducreyi cells (81). Under non-reducing conditions, fibrinogen did not bind 
FgbA indicating that its role in H. ducreyi virulence is unclear. 
Quorum sensing is a process, which allows individual bacteria to regulate gene 
expression based on the local bacterial cell density. In this way, quorum sensing serves as 
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a potent indicator of population density. Autoinducers, such as AI-2, are signaling 
molecules involved in quorum sensing (82). Inactivation of luxS, a critical component in 
synthesis of AI-2, decreases virulence of Vibrio cholerae and A. actinomycetemcomitans 
(82, 83). luxS is necessary for full virulence of H. ducreyi (84). The virulence defect of 
the luxS mutant is a direct result of decreased production of AI-2. Importantly, H. ducreyi 
produces AI-2 that functions in a Vibrio harveyi-based reporter system suggesting that H. 
ducreyi may have a functional quorum sensing mechanism (85).  
The remaining three genes required for virulence are cpxA, hfq, and csrA. These 
genes are putative regulators of the aforementioned virulence determinants and are 
discussed in further detail in the next section. 
 
Haemophilus ducreyi regulators of virulence 
Unlike E. coli and many other gammaproteobacteria, H. ducreyi does not have an 
extensive stress response system. In comparison to E. coli, the H. ducreyi genome is 
relatively small (4.6 vs. 1.7 Mbp). H. ducreyi must use its smaller genome efficiently. For 
example, most bacterial species have multiple 2-component signal transduction systems 
that allow response to stress by altering gene expression (86). In contrast, H. ducreyi only 
appears to have one 2-component system, named CpxRA (85). In E. coli, CpxRA senses 
and responds to envelope stress signaled by misfolded proteins in the periplasm. CpxA is 
a sensor kinase that autophosphorylates when it senses envelope stress. CpxA then 
donates a phosphate group to the response regulator CpxR (which catalyzes the transfer), 
leading to a conformational change that ultimately results in regulation of target genes. 
For example, activation of the system in E. coli stimulates expression of chaperones to 
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alleviate accumulation of misfolded proteins. The H. ducreyi CpxRA system was found 
to downregulate at least 7 genes that encode known virulence factors including dsrA and 
lspA2 (85). In the human challenge model, activation of CpxR by deletion of cpxA 
resulted in complete attenuation of the mutant, while inactivation of the system by 
deletion of cpxR did not affect virulence (87). These data led us to look at other stress 
response systems that may be important for H. ducreyi virulence.  
Cyclic-di-GMP is a small nucleotide important for signal transduction and gene 
expression and has been shown to regulate expression of genes critical for adapting to 
changes in the environment (88). The H. ducreyi genome lacks homologues of 
diguanylate cyclases such as YdeH that synthesize cyclic-di-GMP.  
In the transition from nutrient abundance to starvation, the limited amount of 
available RNAP is redistributed to transcribe genes involved in maintenance and survival. 
Alternative sigma factors are specialized regulatory factors that respond to unique 
environmental stress conditions and increase transcription of genes necessary for each 
stress. Within E. coli, there are 6 such factors: RpoE (Extracytoplasmic/oxidative), RpoH 
(Heat shock), RpoN (Nitrogen stress), RpoS (Stationary/Starvation), RpoF 
(Flagella/motility), and FecI (Iron starvation). The function of these factors is to help 
switch transcriptional activity in response to a large variety of environmental signals. As 
these are highly specialized they are required only for certain physiologically roles.  
Of the above described alternate sigma factors, the H. ducreyi genome has 
homologues of only RpoH and RpoE. RpoS, E. coli’s primary alternate sigma factor, is 
not present. This indicates that unlike E. coli, H. ducreyi must have evolved other 
mechanisms to regulate gene expression without the use of a multitude of sigma factors. 
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Our lab found that RpoE and CpxRA regulate distinct sets of genes in H. ducreyi. 
Interestingly, the sets of genes regulated by RpoE and CpxRA ultimately complement 
one another in an effort to stabilize a stressed membrane (89). RpoE is a major regulator 
of envelope maintenance and repair factors, while CpxRA appears to regulate H. ducreyi 
virulence genes.  
Hfq is an RNA chaperone that binds small regulatory RNA (sRNAs) and mRNAs 
to facilitate mRNA translational regulation in response to envelope stress, environmental 
stress, and changes in nutrient concentrations (90). Hfq functions as a global RNA 
regulator interacting with several hundred different sRNA and mRNA species (91, 92). 
Hfq modulates a myriad of cellular functions; inactivation of hfq significantly impairs 
pathogenicity of several bacterial species. In the absence of an RpoS homolog, Hfq likely 
serves as a major contributor of stationary phase gene regulation in H. ducreyi (93). Hfq 
positively regulates the expression of several virulence determinants including lspB-
lspA2, flp1-3, and dsrA (93). 
In E. coli, CsrA is a global regulator of carbon metabolism. An H. ducreyi csrA 
mutant was partially attenuated and exhibited several profound phenotypic changes in 
stationary phases including increased susceptibility to oxidative stress (94). Furthermore, 
deletion of csrA resulted in downregulation of flp1 and tadA transcripts and Flp1 and 
Flp2 proteins (94). Taken together, this suggests that CsrA, similar to hfq, may be a 
regulator of virulence; however, it is unclear if CsrA regulates any other virulence 
determinants in H. ducreyi. 
H. ducreyi has homologues to another system with well-characterized roles in 
nutrient stress, the stringent response. Despite its reduced genome size, H. ducreyi has 
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homologues for all 3 stringent response mediators previously identified in E. coli. The H. 
ducreyi RelA, SpoT and DksA proteins are 59, 69, and 70% identical to their E. coli 
homologues, respectively. Structural organization of the E. coli and H. ducreyi 
homologues is depicted in Figure 1. The subject of this thesis was to characterize the role 
of the stringent response in H. ducreyi pathogenesis.  
 
 
Figure 1.  Structure of the enzymes that mediate the stringent response in E. coli (A) and H. 
ducreyi (B). Four functional regions have been identified:  the Syn, synthetase domain, the 
HD, hydrolase domain, and the TGS and ACT domains. Functional domains with reduced 
or absent activity are indicated with dashed lines. The bifunctional SpoT protein contains 
both synthetase and hydrolase activities. As depicted in the diagram, the H. ducreyi SpoT 
protein has a deletion of the structural helical and Conserved Cysteine domains. RelA is a 
monofunctional synthetase; the HD domains in the RelA proteins lack the metal ion 
binding sites that give the domain activity. The activity of the SpoT and RelA proteins are 
controlled through their TGS and ACT domains. The DksA functional domain is a C4-
Type Zinc Finger but the Coiled Coil Domain (CC) interacts with RNAP. Note that the 
structures show approximate locations of domains.  
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Section III: 
The (p)ppGpp–mediated Stringent Response 
 
 
The stringent response 
An abscess is a localized accumulation of leukocytes with necrosis and partial 
liquefaction of cells and tissue (95). There is high protein content in the abscess that is 
likely the result of cell and tissue decay. The release of contents from within the cells 
may result in localized changes of nutrient content within the abscess. Stationary phase 
bacteria, cellular exudate, and anaerobic conditions are common in abscesses (96, 97). 
The abscess microenvironment may induce alterations in gene expression as a result of 
entry into stationary phase, anaerobic conditions, changes in pH, and nutrient availability. 
To our knowledge, there are no studies that detail the nutrient content of the skin 
abscess. Understanding the nutrient content of the abscess is important because during 
human infection H. ducreyi will only have access to nutrients within the abscess. There 
are a few studies that determine various contents of abscesses in other locations that can 
give some insight into what may be occurring in a skin abscess. A study of amino acid 
content in brain abscesses found an increased concentration of valine and leucine (8.16 
mMol/L) within the abscess as compared to outside the abscess (2.57 mMol/L) (98). 
Most of the other amino acids found within the abscesses are below 1 mMol/L, which 
may lead to amino acid starvation in the invading bacteria. In terms of fatty acid content, 
the majority of fatty acids detected in pyogenic liver abscesses are volatile short chain 
fatty acids such as butyric and acetic acid that perturb fatty acid biosynthesis in bacteria 
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(99, 100). Concentrations of other nutrients are unknown. The abscess, therefore, is likely 
a nutrient limiting environment.  
In bacteria, nutrient starvation induces the stringent response. The response is 
mediated by the alarmone guanosine tetraphosphate (ppGpp) and guanosine 
pentaphosphate (pppGpp), collectively referred to as (p)ppGpp. (p)ppGpp synthetases 
and hydrolases are highly conserved in β- and γ-proteobacteria (101). The stringent 
response is induced by amino acid, fatty acid, carbon, phosphate, and iron starvation, and 
heat shock (102-105). The mechanism by which ppGpp levels are controlled is well 
characterized in E. coli (Figure 2).  
The enzyme RelA synthesizes (p)ppGpp from ATP and GTP during amino acid 
starvation. (p)ppGpp then interacts with RNA polymerase (RNAP) to regulate gene 
expression. Through recognition of specific discriminator regions upstream of 
transcription start sites, (p)ppGpp upregulates genes critical for survival and increases 
usage of alternative sigma factors, while genes involved in protein synthesis are 
downregulated. To turn off the response, E. coli utilizes the bifunctional enzyme SpoT. 
SpoT can synthesize (p)ppGpp but is primarily involved in hydrolysis of ppGpp back to 
GTP and ATP.  
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To enhance the stringent response, (p)ppGpp interacts with a co-factor known as 
DnaK Suppressor, or DksA, that helps to stabilize (p)ppGpp’s interaction with RNAP by 
interacting with the secondary channel of RNAP (106). In addition to its role in the 
stringent response, DksA can act independently of (p)ppGpp. DksA is involved in 
multiple processes in bacteria including quorum sensing and regulation of cell division. 
DksA functions similarly to transcription factors; however, unlike most transcription 
factors, DksA does not bind DNA (107). Interestingly, DksA is required for repair of 
double stranded breaks in the chromosome when there are two or more damaged 
locations (108). DksA is also hypothesized to help replication because it removes 
Figure 2.  Diagram of the bacterial stringent response system. Two parallel pathways 
synthesize (p)ppGpp from ATP and GTP in response to any of several  nutrient stress signals. 
Together with DksA, (p)ppGpp alters gene expression through direct interaction with RNAP. 
PPi, pyrophosphate. 
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transcription roadblocks; this is why DksA is thought to be so critical for replication in 
vitro. In fact, in vitro transcription models suggest that halted replication occurs in dksA 
mutants more frequently than in wild type bacteria (109). It is also important to note that 
DksA helps facilitate binding of the housekeeping sigma factor, σ70, to promoter DNA 
during all phases of growth (110, 111). Thus, DksA is considered a major contributor to 
bacterial transcription as well a global regulator of gene expression. 
(p)ppGpp also regulates gene expression indirectly. (p)ppGpp binds to the core 
domain of RNAP and competes with σ70. This interaction allows RNAP to bind to 
alternative sigma factors (112). Additionally, (p)ppGpp induces expression of mRNAs in 
Legionella pneumophila and E. coli that regulate activity of the carbon storage regulator 
A (CsrA) (39). CsrA binds regulatory RNA to control processes such as protein secretion. 
Thus, through regulation of RNAs that regulate CsrA, (p)ppGpp indirectly controls gene 
expression. (p)ppGpp also prolongs the half-lives of mRNA by inhibiting transcription of 
pcnB (poly(A) polymerase) in Actinomycetes (113). (p)ppGpp interacts with and modifies 
the activity of two translational GTPases in E. coli, EF-G and IF2 (114). (p)ppGpp 
inhibits the activity of these GTPases, thereby indirectly inhibiting translation. (p)ppGpp 
also inhibits DNA primase, which is responsible for initiating DNA replication in 
Bacillus subtilis (82).  
In E. coli, both (p)ppGpp and DksA directly affect activities of RpoH, RpoS, 
RpoE, and RpoN (115-117). Induction of the stringent response, helps shift bacteria away 
from active growth and σ70-mediated transcription and redistribute RNAP to promoters of 
maintenance and survival-related genes. Through their interaction with RNAP, (p)ppGpp 
and DksA facilitate transition to the alternate sigma factors and allow for more effective 
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competition against σ70. For example, stringent response activation increases stationary 
phase synthesis of RpoS in E. coli (118, 119). DksA in particular has a key interaction 
with RpoS in stationary phase and during the stringent response (92, 107, 119). The 
affinity of DksA to the core RNAP is ten times greater than to the open complex 
suggesting that DksA’s interaction with RNAP is not limited to the stringent response 
(120). Critical for this study, DksA and (p)ppGpp also stimulate transcription of RpoE 
and RpoH promoters (117). As RpoE and RpoH are the only alternative sigma factors H. 
ducreyi possesses, this may indicate a role for the stringent response in alternative sigma 
factor usage in H. ducreyi.  
The stringent response is also involved with Hfq. DksA is involved in regulation 
of transcription of Hfq in exponential phase as well as stringent response (121). The 
enzyme RelA directly interacts with the Hfq protein. In E. coli, Hfq functions as a 
homohexameric ring in RNA binding. RelA is required for stimulation of multimerization 
of Hfq, increases the levels of the active form of Hfq, which enables binding of RNAs 
(122). It is unknown if this stimulation is a stoichiometric or catalytic reaction. 
Importantly, (p)ppGpp does not appear to directly interact with Hfq, however, (p)ppGpp 
interaction with RNAP may increase expression of an Hfq regulator. Thus, both 
(p)ppGpp and DksA have significant roles beyond the stringent response. 
 
Bacterial virulence and the stringent response 
The (p)ppGpp mediated stringent response has been shown to be important for 
virulence in pathogenic E. coli and several other pathogenic bacterial species. (p)ppGpp° 
mutants of Yersinia pestis, Salmonella enterica serovar Typhimurium, and Borrelia 
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burgdorferi are completely avirulent in animal models of infection (123-125). (p)ppGpp° 
mutants of Staphylococcus aureus, Pseudomonas aeruginosa, Mycobacterium 
tuberculosis, and Enterococcus faecalis are partially attenuated in their wild-type parents 
in their respective animal models of infection (126-129). Uropathogenic E. coli, a leading 
cause of acute urinary tract infections, require type 1 fimbriae for adherence to 
uroepithelial cells. (p)ppGpp is required for activation of the fim operon, which confers 
expression of the Type 1 fimbriae (130). SpoT is required for expression of Yersinia’s 
secreted virulence factors (83). The (p)ppGpp-mediated stringent response is essential for 
expression of Pla, a key protease responsible for promoting invasion of Yersinia into 
epithelial cells (124). Vibrio cholerae required RelA for expression of virulence genes 
needed to help it adapt to changing environments during transmission (131). 
DksA plays a role in bacterial virulence separate from (p)ppGpp. In E. coli, in 
vitro studies show that DksA protein levels remains constant throughout bacterial growth. 
dksA mutants have defects in chaperonin function, gene expression, cell division, amino 
acid biosynthesis, quorum sensing and virulence (107). In Shigella flexneri, DksA is 
essential for regulation of hfq, which is an important regulator of S. flexneri virulence 
genes (121). DksA expression is typically  increased under acidic conditions and 
oxidative stress. Shigella flexneri dksA mutants have increased sensitivity to acidic and 
oxidative stress (132). DksA also contributes to the resistance of S. enterica serovar 
Typhimurium to reactive nitrogen species produced by inducible nitric oxide synthase 
(iNOS) and Nitric Oxide (NO) (133). In UPEC, DksA is important for the regulation of 
cell-to-cell adhesion between bacterial cells and adherence to eukaryotic cells 
independent of (p)ppGpp (134). DksA regulates motility, expression of the hemagglutinin 
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protease, and production of cholera toxin in Vibrio cholerae, all processes related to 
virulence (135). DksA is also involved in the posttranscriptional control of rhamnolipids 
and LasB elastase, which are involved in quorum sensing in Pseudomonas aeruginosa 
(136).  
During human infection, multiple genes involved in stress response are 
upregulated in H. ducreyi (73). Genes critical for DNA repair such as mutL (DNA 
mismatch repair protein) and recB (dsDNA break repair) are upregulated in vivo. 
Likewise several stress response components including rpoE (alternative sigma factor), 
htpX (probable heat shock protein) and relA (a component of the stringent response) are 
also upregulated during human infection (73). In addition, the doubling time of H. 
ducreyi in nutrient-rich media is 2 hours while the estimated doubling time is 16 hours in 
human lesions (49). During human infection, the environment is hostile and H. ducreyi, 
like other pathogens, might need to modify gene expression to survive.   
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Hypothesis 
 
We hypothesized that the stringent response is required for virulence of H. 
ducreyi in humans. The rationale for this hypothesis is derived from three sources. First, 
the H. ducreyi genome encodes genes with high homology to relA, spoT, and dksA; 
previously identified as key players in the stringent response. Second, the minimum 
estimated doubling time of H. ducreyi in vivo is approximately 16 hours while the in vivo 
doubling time in nutrient rich media is 2 hours. This suggests that H. ducreyi experiences 
nutrient limitation in the human host. Lastly, the relA homolog is upregulated in pustules 
from infected volunteers, strengthening the hypothesis that H. ducreyi experiences 
nutrient limitation in vivo.   
Taken together, these data suggest that H. ducreyi might utilize the stringent 
response to adapt to nutritional stress during human infection. To address this hypothesis, 
our Specific Aims were to: (1) Construct and characterize in vitro virulence-associated 
phenotypes of ∆relA, ∆relA∆spoT and ∆dksA mutants; (2) Evaluate ∆relA∆spoT and 
∆dksA mutants for abscess formation compared to the parent strain in human volunteers; 
(3) Determine the transcriptome of the (p)ppGpp and DksA deficient mutants compared 
to the parent strain.   
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Chapter II: 
 
Materials and Methods 
 
Bacterial strains and growth conditions. The bacterial strains used in this study 
are listed in Table 1. H. ducreyi strains were grown on chocolate agar plates 
supplemented with 1% IsoVitalex at 33°C with 5% CO2 or in GC broth supplemented 
with 5% fetal bovine serum, 1% IsoVitalex and 50 μg/ml hemin (Aldrich Chemical Co.) 
at 33°C. H. ducreyi 35000HP was grown to mid-log (optical density at 660 nm [OD660] = 
0.2), transition  (OD660 = 0.35), or stationary phase (OD660 = 0.5); mutant strains were 
harvested when the OD660 of 35000HP was in the appropriate range for each phase of 
growth. E. coli strains were grown in Luria-Bertani medium at 37°C with the exception 
of strain DY380, which was maintained in low salt broth or agar at 32°C and grown at 
42°C for induction of the lambda red recombinase. When necessary, medium was 
supplemented with kanamycin (20 μg/ml for H. ducreyi; 50 μg/ml for E. coli) or 
spectinomycin (200 μg/ml for H. ducreyi; 50 μg/ml for E. coli). For H. ducreyi strains 
containing a pACYC177 backbone, medium was supplemented with 30 μg/ml 
kanamycin. 
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Characterization of the relA, spoT and dksA genes. The Basic Local Alignment Search 
Tool (BLAST) was used to identify putative homologues of relA, spoT and dksA in H. 
ducreyi (GenBank accession no. AE017143). RT-PCR was conducted to determine if 
target genes were in operons with surrounding genes. Primers used for RT-PCR are found 
in Table 2. 
 
Table 1. Bacterial strains used in this study 
Strain(s) Descriptiona Source or reference(s) 
E. coli strains      DH5α, Top10, and 
 
Strains used for general cloning procedures Invitrogen 
  DY380 DH10B derivative containing a defective λ 
prophage in which the red, bet, and gam genes are 
controlled by the temp-sensitive λcI857 repressor 
(137) 
  CF1693 ΔrelAΔspoT deletion mutant in MG1655 (138) 
  CF1652 ΔrelA deletion mutant in MG1655 (138) 
  MG1655 Wild type strain E. coli strain (138) 
   
H. ducreyi strains   
  35000HP Human-passaged variant of strain 35000 (37) 
  35000HPΔdksA Unmarked, in-frame dksA deletion mutant This study 
  FX517 35000HPΔdsrA:: cat insertion mutant (77) 
  35000HPΔflp1-3 Unmarked, in-frame flp1-2-3 deletion mutant (70) 
  35000HP.400 35000HPΔtadA:: cat insertion mutant (72) 
  35000HPΔrelA Unmarked, in-frame relA deletion mutant This study 
  35000HPΔrelAΔspoT Unmarked, in-frame relA and spoT double deletion 
mutant 
This study 
  35000HPΔsodC 35000HPΔsodC:: cat insertion mutant (139) 
  HD183 Class I isolate; Singapore 1982 --- 
  82-029362 Class I isolate; California 1982 --- 
  33921 Class II isolate; Kenya, unknown --- 
  CIP542 Class II isolate; Hanoi 1954 --- 
  NZS3 CUD Isolate; Samoa 2006 --- 
  NZS4 CUD Isolate; Samoa 2007 --- 
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Table 2. Primers used in this study 
Primer Gene Purpose 5' to 3' sequencea 
P1 dnaE int 5’ colony hybridization, 
qRT-PCR 
AACGTTACCTTCAGCAAGCGGTTC 
P2 dnaE int 3’ colony hybridization, 
qRT-PCR 
GGCGTTTGGGATCGTCGAGTGTAT 
P3 relA int  5’ mutagenesis, colony 
hybridization 
CGCGCGGTACGGGTGATTGT 
P4 relA int 3’ mutagenesis, colony 
hybridization 
TGGCGCGCGCTTTTGAGGTA 
P5 spoT int 5’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   mutagenesis, colony 
hybridization 
CCAGTCGCGGTTGCCACCAT 
P6 spoT int 3’ mutagenesis, colony 
hybridization 
CACGCCCGTAAACACGGCCT 
P7 relA-dxr, 5' RT-PCR GCGATGTAAGTGCTGTGATGGCAA 
P8 relA-dxr, 3' RT-PCR TTCGCCGGTTAATACTTGGGTGGT 
P9 recG-rpoZ, 5' RT-PCR TGGCACTAAACAAACGGGTATGGC 
P10 recG-rpoZ, 3' RT-PCR ATCGCTTCTTGTTCAGCCACCTCT 
P11 rpoZ-spoT, 5' RT-PCR TAACCGTCCAAGAAGCTGCCGATA 
P12 rpoZ-spoT, 3' RT-PCR AAGGCTCACCACTAGAGCGAGTTT 
P13 spoT-menB, 5' RT-PCR AATTGATCAGAGTCCGCGGTGTGA 
P14 spoT-menB, 3' RT-PCR ATGATCGACCCATTCAATCGGAGC 
P15 RelA Homology 
1 
relA and mutagenic 
cassette homology 
primer, Forward 
ACTGTGTAAGCAGTTCAATTCTCT
CATTATTTTGCAAAGGAGGTTTTA
TGATTCCGGGGATCCGTCGACC 
P16 RelA Homology 
2 
relA and mutagenic 
cassette homology 
primer, Reverse 
TTGCTACTTAAAACTGACCGCTTA
TTCAATTAGTTTGCTAGCCGTTTTG
CTGTAGGCTGGAGCTGCTTCG 
P17 relA 
amplification, F 
relA ORF and 500bp 
upstream 
ATATATACTAGTCTGCAATATTAG
CATGGCCATATTTACGGT 
P18 relA 
amplification, R 
relA ORF and 500bp 
downstream 
ATATATACTAGTTGCCCGCATGTC
ACTAAAGATTC 
P19 SpoT Homology 
1 
spoT and mutagenic 
cassette homology 
primer, Forward 
AGCCTTATATTACTCATCCAGTCG
CGGTTGCCACCATTATTGCTGAAA
TGATTCCGGGGATCCGTCGACC 
P20 SpoT Homology 
2 
spoT and mutagenic 
cassette homology 
primer, Reverse  
AGATTTGCGAATGAGACCGCTTGT
AACGACTAGGCGCTGACTTTTGCC
ACTGTAGGCTGGAGCTGCTTCG 
P21 spoT 
amplification, F 
spoT ORF and 500bp 
upstream  
ATATATACTAGTATTACAACTTCA
CGTTCGTGAGCCGC 
P22 spoT 
amplification, R 
spoT ORF and 500bp 
downstream 
ATATATACTAGTCTGCTACCATTG
CTACTACGGGTT 
P23 spec, 5’ mutagenesis ATTCCGGGGATCCGTCGACC 
P24 spec, 3’ mutagenesis TGTAGGCTGGAGCTGCTTCG 
P25 relA, 5' qRT-PCR TACACCGCGTGGTGAAGTGATTGA 
P26 relA, 3' qRT-PCR TAGCGCCTATACAACGATGCCCAA 
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P27 spoT, 5' qRT-PCR CTTTCAAGCCATGCATCCTTATC 
P28 spoT, 3' qRT-PCR CACGGATTTGGTATGGTCTAGG 
P29 dxr 5’ qRT-PCR AGTTATGGCAGCGATTGTTGGTGC 
P30 dxr 3’ qRT-PCR ACTTGCGTTAAATAGCCAGCGTGC 
P31 menB  5’ qRT-PCR TGGTCCGAAAGTCGGTTCCTTTGA 
P32 menB  3’ qRT-PCR ATAGAACAGCATGGTTGCGTTGCC 
P33 cat promoter, R cat promoter of 
pACYC184 for 
complement (#1), 
upstream 
CATATGATATCTAGAATATTTAGC
TTCCTTAGCTCCTG 
P34 cat promoter, F cat promoter of 
pACYC184 for 
complement (#1), 
downstream 
ATCCTGTCGGCTGTGGCACAGGCT
GAACGCCGGAGGATCCGTTGATAC
CGGGAAGCCCTGGGCCAAC 
P35 spoT ORF, F spoT fragment (#2) for 
complement, upstream 
GGAGCTAAGGAAGCTAAATATTCT
AGATATCATATGAATTGCCATATT
GTGAGGTGAAATTTG 
P36 spoT ORF, R spoT fragment (#2) for 
complement, 
downstream 
CATATGATACTAGGCGCTGACTTT
TG 
P37 relA ORF, F relA fragment (#3) for 
complement, upstream 
GCAAAAGTCAGCGCCTAGTATCAT
ATGAGTTCAATTCTCTCATTATTTT
GCAAAGGAGGTTTT 
P38 relA ORF, R relA fragment (#3) for 
complement, 
downstream 
TTTGCTTCCTGTCGGCCCTCATTCG
TGCGCTCTAGGATCCTCTAGAATA
CTATTATCCTTCATTTTTTATACAA
 P39 tbpA-dksA, 5' RT-PCR ACGGAAGTGGATCCAGCATTTGTC 
P40 tbpA-dksA, 3' RT-PCR TAGCACGATCAGGATCAGCAA 
P41 dksA-pcnB, 5' RT-PCR TCGTCCGACTGCGGATATGTGTAT 
P42 dksA-pcnB, 3' RT-PCR TTCGCTTTGCTAAGGCTTCACTGC 
P43 pcnB- folK, 5' RT-PCR GTTGAATTATCGGCGTGGTGGCAT 
P44 pcnB- folK, 3' RT-PCR TGTGGCCCTATTGGCTGACTACAA 
P45 dksA int, 5' mutagenesis, colony 
hybridization 
TGCTGATCCTGCTGATCGTGCT 
P46 dksA int, 3' mutagenesis, colony 
hybridization 
TCCGCAGTCGGACGAGCTTCT 
P47 dksA 
amplification, F 
dksA ORF and 500bp 
upstream 
ATATATACTAGTGGCTGCTGAATT
TGAAGAAGGCCA 
P48 dksA 
amplification, R 
dksA ORF and 500bp 
downstream 
ATATATACTAGTCAGGTTTAGCAT
TAGTGGCAATATCC 
P49 DksA 
Homology 1 
dksA and mutagenic 
cassette homology 
primer, Forward 
AGTTATATTCAAAGATCAGGCTGA
CTTATCCAACAAGGAGTGCAATTA
TGATTCCGGGGATCCGTCGACC 
P50  
DksA 
Homology 2 
dksA and mutagenic 
cassette homology 
primer, Reverse 
CATTGTCCATTCCTATGTACCTATA
CTAACTAAAGCCCCATTTGTTTCTC
TGTAGGCTGGAGCTGCTTCG 
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P51 dksA ORF, F dksA fragment (#2) for 
complement, upstream 
ATATATTCTAGACAAAGATCAGGC
TGACTTATCATG 
P52 dksA ORF, R dksA fragment (#2) for 
complement, 
downstream 
ATATATTCTAGAATTCCTATGTAC
CTATACTAACTA 
P53 tbpA, 5’ RT-PCR ATGCCTGAGGCGGTTAAAT 
P54 tbpA, 3’ RT-PCR GCTCGTGCCAATAATGGTATAAAG  
P55 dksA, 5' qRT-PCR GTGCATGGCACGTGCAAATTATGG 
P56 dksA, 3' qRT-PCR TCTTCTTGGGTAGCACGATCAGCA 
P57 pcnB, 5' qRT-PCR AGTGGGTGGGTGTATCCGTGATTT 
P58 pcnB, 3' qRT-PCR TAAATCGCACCGCGCGTAACATTC 
P59 lspB, 5’ qRT-PCR AGCTAGAGCGGCTGACCCATTAAA 
P60 lspB, 3’ qRT-PCR GTGAGAAATTGCTCCGCTTTGGCT 
P61 flp1, 5’ qRT-PCR GGTTAATTGCAGTCGCAGTTGCT 
P62 flp1, 3’ qRT-PCR GTGCCATTAGCGCTACTTATACCA
 P63 tadA, 5’ qRT-PCR AATCAATGCCTTGCGTATGCGTCC 
P64 tadA, 3’ qRT-PCR TGTATTGGCGTGCAGGGTAGACAT 
P65 cpxA 5' qRT-PCR GCCATTCCTAATTTCGATGCGCGT
 P66 cpxA 3' qRT-PCR TTTGAGTGGCTACAGAAAGGCGAC 
P67 oxyR 5' qRT-PCR CTTGTTGAACAGGCCAAAGCGGTA 
P68 oxyR 3' qRT-PCR GTGCAATGGGCCAGACATTTCCTT 
P69 sodC 5' qRT-PCR GGCCATTGGGATCCAAAGCAAACT 
P70 sodC 3' qRT-PCR CAGGCGTTGTTGCTGAACCATCAT 
P71 ccmD, 5’ qRT-PCR CGCAGATTTCTTTGCGATGGGA 
P72 ccmD, 3’ qRT-PCR CTCGGTAAGACAACCAAATTAGCC
 P73 HD1577, 5’ qRT-PCR TAAATCAAGCGCTCGCACCGAAAC 
P74 HD1577, 3’ qRT-PCR AAACACACATTGTGGCGTGCCTTC 
P75 sapF, 5’ qRT-PCR TATTGGGCAGATTCTTGATGCGCC 
P76 sapF, 3’ qRT-PCR CCCTTGCAAGTGCAATCCGTTGTT 
P77 HD1904, 5’ qRT-PCR AGCTAACTATTCATTAGACGACCT 
P78 HD1904, 3’ qRT-PCR AAGGCAATTTGTGGGAAATACT 
P79 tadB, 5’ qRT-PCR GCAACCTCTTCAGGTGTTAGT  
P80 tadB, 3’ qRT-PCR GCTTCTGCTGTCATTGCTTTC 
P81 rfaD, 5’ qRT-PCR TATATGCTTCTAGCGCGGCCACTT 
P82 rfaD, 3’ qRT-PCR CGCTTGCCATCGACCCTTTATGTT 
P83 HD0457, 5’ qRT-PCR GCGTAATGATGGAAATGTCTCAAA  
P84 HD0457, 3’ qRT-PCR TCCGCTAACTCTTTAGCTTTCTT 
P85 lspA1, 5’ qRT-PCR CCGGAATTAAGTGGCTATGGT 
P86 lspA1, 3’ qRT-PCR GCGATAAGCGCGGTCAATA 
P87 glpF, 5’ qRT-PCR CGCCTGTATCGCAGAATGTAT 
P88 glpF, 3’ qRT-PCR ACAAGTGCCGCAGCTAAA  
P89 degP, 5’ qRT-PCR AGGGCAAACGGTGACATCTGGTAT 
P90 degP, 3’ qRT-PCR AACTCACCGCCTTTAATGCCCAAC 
P91 HD1218, 5’ qRT-PCR GCTCAGAGAATGAAATCACCAAA
 P92 HD1218, 3’ qRT-PCR TTATCGTTGGCTAGGAGTGTTG 
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P93 hfq, 5’ qRT-PCR TCGAGAGCGTATTCCCGTCTCAAT 
P94 hfq, 3’ qRT-PCR TGTACGGCTTGTTGAGGAGCTTGT 
P95 ompP2A 5’ qRT-PCR TGCTAAAGGAGAAGCGTTAGAC 
P96 ompP2A 3’ qRT-PCR TAGCCAAGCGCCATTTGA 
P97 HD0098 5’ qRT-PCR ACAAAGAATTGTCAGGATTGGC 
P98 HD0098 3’ qRT-PCR GAGTAGTAACAACAGCTCCATCA 
aBoldfaced text represents sequences with homology to the mutagenic cassette. Underlined text 
indicates regions corresponding to restriction enzyme sites as mentioned in the text. H. ducreyi 
sequences are from GenBank accession no. AE017143. 
 
 
Recombineering in H. ducreyi. Unmarked, in-frame deletion mutants were constructed 
using the λ red and FLP recombinase method described previously (85, 140). The method 
is summarized in Figure 3. To construct a deletion mutant, PCR was used to amplify the 
spectinomycin resistance cassette (spec) flanked by flippase recognition target (FRT) 
sites from pRSM2832. The forward primer includes 47 bp upstream of and the ATG start 
codon of the target gene. The reverse primer includes the final 21 bp at the 3’ end of the 
target, the stop codon and 29 bp downstream. Plasmids constructed and used for 
mutagenesis are found in Table 3.  
The coding region of the target along with a 0.5-kb flanking region on either side 
of the gene was amplified. The product was cloned into pCR-XL-TOPO® and then 
electroporated into E. coli DY380, which contains a temperature sensitive λ red 
recombinase. The spec cassette containing PCR product was electroporated into the 
DY380 strain generated above. Following induction of the recombinase, the target gene 
was replaced with the spec cassette with the exception of the start codon and the last 21 
bp of the gene. The spec cassette containing the flanking regions was digested with SpeI 
and cloned into the suicide vector pRSM2072. This construct was electroporated into 
35000HP. Chocolate agar containing spectinomycin and X-gal was used to select clones 
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in which allelic exchange had occurred. PCR and sequence analysis confirmed 
replacement of the target gene with the spec cassette.  
 
 
 
FLP recombinase was used to remove the spec cassette as described previously 
(140). In place of the target ORF, the final mutant carries a scar ORF which contains the 
target gene’s start codon, the FRT sequence, and the last 21 nucleotides of the target 
including the stop codon. PCR and sequence analysis then confirmed removal of the spec 
cassette. qRT-PCR was performed to ensure that the gene deletion was non-polar.   
Figure 3. Mutagenesis strategy in H. ducreyi. Gene knockout primers have 20- to 30-nucleotide 
ends for priming upstream (P1) and downstream (P2) of the FRT sites flanking the resistance 
gene and 500-nucleotide ends homologous to upstream (H1) and downstream (H2) 
chromosomal sequences for the target genes. H1 includes the target start codon. H2 includes 
codons for the six C-terminal residues, the stop codon, and 21 nucleotides downstream. 
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Table 3. Plasmids used in this study 
Plasmid Name Description Source or 
 Plasmidsa   pRSM2832 Plasmid containing spectinomycin resistance 
cassette flanked by the FRT sites 
(141) 
pRSM2072 H. ducreyi suicide vector (140) 
pRSM2975 Plasmid containing the origin of replication and 
kanamycin-resistance gene from pLS88, FLP 
recombinase gene from pFT-A and a point 
mutation conferring a temp-sensitive phenotype in 
H. ducreyi 
(87) 
   pCH1 pCR-XL-TOPO containing the relA-coding region 
along with 0.5- kb flanking regions 
This study 
   pCH11 pCR-XL-TOPO containing the spoT-coding 
region along with 0.5- kb flanking regions 
This study 
pACYC177 Cloning vector, Kanr Ampr for complementation New England 
Biolabs 
pACYC184 Cloning vector, Cmr Tetr New England 
Biolabs 
pCH4 pACYC177 containing the 35000HP relA gene 
with the cat promoter from pACYC184 
This study 
   pCH30 pACYC177 containing the 35000HP relA and 
spoT gene with the cat promoter from 
pACYC184 
This study 
pCH21 pCR-XL-TOPO containing the dksA-coding 
region along with 0.5- kb flanking regions 
This study 
pCH24 pACYC177 containing the 35000HP dksA gene 
with the cat promoter from pACYC184 
This study 
pCH31 pACYC177 containing the cat promoter from 
pACYC184 
This study 
aPlasmids are listed in the order in which they appear in text. 
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RNA isolation and quality assessment. Total RNA was extracted from 35000HP, 
35000HPΔrelAΔspoT, and 35000HPΔdksA in the mid-log, transition, and stationary 
growth phases using TRIzol reagent (Invitrogen) according to the manufacturer's 
protocol. RNA isolation was performed on four independent bacterial cultures for each 
strain in each growth phase. RNA was treated twice with the TURBO DNA-free DNase 
(Ambion). The integrity and the concentration of RNA were determined using the 
Agilent 2100 Bioanalyzer (Agilent Technologies) and the NanoDrop ND2000 
(ThermoScientific), respectively. The efficacy of DNase treatment was confirmed by 
reverse transcriptase PCR (RT-PCR) analysis of dnaE with the primer pair P1/P2 (Table 
2). 
 
Reverse transcriptase PCR (RT-PCR) and quantitative RT-PCR (qRT-PCR). cDNA 
was synthesized from total RNA using Advantage RT-for-PCR kit (Clontech). RT-PCR 
was performed using the cDNA and FastStart PCR Master mix (Roche). qRT-PCR was 
performed using the QuantiTect SYBR Green RT-PCR kit (Qiagen) and a Mastercycler® 
Ep Realplex 4 (Eppendorf). All primer pairs used for qRT-PCR (Table 2) had greater 
than 95% amplification efficiency. Relative expression was calculated as 
[(EtargetΔCTtarget)/(EreferencceΔCTreference)], where E is the amplification efficiency (10-1/slope) 
and the ΔCT is the change in cycle threshold. dnaE was amplified to normalize the 
expression levels of target genes. 
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Construction of complementation plasmids. To complement the ΔrelAΔspoT and 
ΔdksA mutants, genes were expressed under the control of a constitutive cat promoter 
from pACYC184 in the expression vector pACYC177. The cat promoter was amplified 
from pACYC184. Specific fragments used to construct the individual complementation 
plasmids are described in subsequent chapters. The PCR fragments were combined with 
BamHI digested pACYC177 in a Gibson assembly reaction (142). Briefly, the three 
fragments were incubated in a reaction mixture (kindly provided by M. Goebl, Indiana 
University) that contained T5 exonuclease (Epicentre), Phusion Taq (New England 
Biolabs), and Taq DNA ligase (New England Biolabs) at 50°C for 1 hour. The final 
constructs were confirmed by PCR and sequence analysis. Strains containing pACYC177 
were used as controls.  
Although all transformed strains grew well on antibiotic supplemented plates, H. 
ducreyi strains containing pACYC177 grew poorly in antibiotic-supplemented broth. 
Kanamycin dose response growth curves confirmed that only the 35000HP pACYC177-
containing strains grown in the absence of kanamycin grew as well as 35000HP in broth 
(Figure 4). Furthermore, strains transformed with pACYC177 could be grown in broth 
without antibiotics for only 6 hours before losing the plasmid. Thus, use of the 
complemented strains was limited to those assays using cells that had been grown or 
maintained in broth without antibiotics for 6 hours or those that had been grown on plates 
supplemented with antibiotics.  
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Human inoculation experiments. Human inoculation experiments were conducted 
according to the guidelines of the U.S. Department of Health and Human Services and 
the Institutional Review Board (IRB) of Indiana University. All volunteers gave written, 
informed consent for participation and HIV-1 serology. The procedures for the human 
inoculation experiments, including calculation of the estimated delivered dose (EDD), are 
described in detail elsewhere (47). Briefly, healthy adult volunteers are inoculated 
with H. ducreyi at multiple sites on the upper arm using an allergy testing device. Based 
on the delivery characteristics of the allergy testing device, the EDD is calculated by 
dividing the CFU loaded on the device by 1000 (12). Volunteers remain infected until 
one of three clinical endpoints is reached: (1) resolution of disease at all sites, (2) 
development of a pustule that is either painful or > 4 mm in diameter, or (3) 14 days after 
Figure 4. Growth curve of 35000HP containing pACYC177 in increasing concentrations of 
kanamycin compared to 35000HP grown in the absence of kanamycin. 
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inoculation. At endpoint, all volunteers are treated with one dose of oral ciprofloxacin. 
Papule and pustule formation rates for parent and mutant inoculation sites were compared 
using logistic regression with generalized estimating equations (GEE) as previously 
described (72). Ninety-five percent confidence intervals (95% CI) for papule and pustule 
formation rates were calculated using GEE-based sandwich standard errors.  
To ensure that there was no cross contamination of samples, colony hybridization 
was performed on colonies derived from the inocula, surface cultures, and biopsies. 
Probes specific for the deleted gene(s) and dnaE were designed and the DIG DNA 
labeling kit (Roche Applied Sciences) used to label the probes with digoxigenin. The 
DIG Easy Hyb protocol was performed according to manufacturer’s instructions (Roche 
Applied Sciences). 
 
LOS preparation. Bacterial suspensions in 50 mM NaH2PO4/ 5 mM EDTA were 
sonicated and incubated with 1 mg/ml lysozyme at room temperature with stirring. A 
mixture of 50 mM NaH2PO4/ 45 mM MgCl2, 4 mg/ml lysozyme, 30 μg/ml DNase and 30 
μg/ml RNase was added and incubated overnight at 37°C. Proteinase K was added and 
the mixture incubated at 56°C for 2 hours, then 75°C for 1 hour. The bacteria were 
pelleted and the mixture suspended in 300 μl dH20. The liquid was transferred to a dram 
vial with a micro stir bar. An equal volume of hot 90% phenol was added to a dram vial 
and the mixture was stirred vigorously for 15 mins at 65°C, incubated on ice for 10 mins, 
and then centrifuged for 10 mins at 4°C.  The top aqueous phase was extracted twice, 
then the preparations were ethanol-precipitated, resolved on LOS gels and silver stained 
to visualize the LOS bands. 
 
 
39 
Outer membrane preparation. Bacteria were grown in 225 ml broth culture in side arm 
flasks for 16 hours. The culture was collected and centrifuged at 10000 x g for 20 mins at 
4°C. The pellet was washed in cold 10 mM HEPES and centrifuged. The preparations 
were sonicated for 10 mins on ice and spun at 7000 rpm for 30 mins at 4°C. The 
supernatant was collected and transferred to ultracentrifuge tubes and centrifuged at 
100000 x g for 60 mins at 4°C. To separate the outer membrane proteins, the pellet was 
suspended in an equal volume of HEPES buffer and 2% sodium lauryl sarcosinate in 
HEPES and incubated at room temperature for 30 mins with gentle rocking. After 
incubation, the tubes are centrifuged.. The supernatant is removed and the pellet was 
incubated with dH20 at 4°C overnight.  
 
Antibodies and immunoblots. Polyclonal antibodies against OmpP2A, OmpP2B, 
Flp1/2, and DsrA were used in this study. Anti-sera for Flp1/2 (kindly provided by E. 
Hansen, University of Texas Southwestern), OmpP2A and OmpP2B (A. Campagnari, 
SUNY-Buffalo), and DsrA (C. Elkins, University of North Carolina) were used to detect 
their respective proteins. Mabs 3B9 and 2C7 were used to detect PAL and 
MOMP/OMPA2 respectively and are described elsewhere (143, 144). Immunoblots were 
performed on whole cell lysates and purified outer membranes.  
 
Tandem mass spectrometry (LC-MS/MS). An 8% SDS-PAGE gel containing purified 
outer membranes of 35000HP and 35000HP∆relA∆spoT was stained with Coomassie 
dye. The protein band of interest was isolated at the Indiana University School of 
Medicine Proteomics Core Facility. The excised band was subjected to liquid 
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chromatography followed by tandem mass spectrometry. Analysis showed that the 
protein band contained peptides mapping to multiple proteins. Only proteins with high 
peptide confidence levels (over 90%) were reported. Identified proteins with at least 2 
unique peptide matches were considered for further analysis.  
 
De novo (p)ppGpp synthesis assay. For detection of (p)ppGpp synthesis in H. ducreyi, 
we modified two published assays (145, 146). Briefly, H. ducreyi strains were grown in 
GC broth. At different phases of growth, the bacteria were harvested by centrifugation, 
washed in phosphate-limited RPMI (US Biological Life Sciences) and suspended (1 x 105 
cells/ml) in phosphate-limited RPMI. Pilot experiments showed that there was no 
reduction in bacterial viability for up to 4 hours in this media. For the labeling 
experiments, the bacteria were suspended in phosphate-limited RPMI media 
supplemented with 5% FBS and KH232PO4 (specific activity, 900-1100 mCi/mmol; 
Perkin Elmer) at 100 μCi/ml. The bacteria were incubated for 3 hours, washed, and 
incubated for an additional 15 mins in phosphate-limited RPMI. For extraction of 
(p)ppGpp, cells were treated with 40 mg/ml lysozyme in 10 mM Tris HCl (pH 8.0) for 20 
mins and lysed on ice using 1% SDS (w/v) for 20 mins. Finally, an equal volume of 13 M 
formic acid was added to the lysate, which was incubated on ice for 15 mins. Cell debris 
was removed by centrifugation. A sample of the supernatant containing the extracted 
(p)ppGpp was spotted onto PEI TLC plates (Sigma Aldrich). (p)ppGpp was separated in 
1.5 M H3PO4 (pH 3.4) buffer and detected using autoradiography. The film was then 
exposed at -80°C in an x-ray film cassette. CTP, ATP, and GTP standards (Sigma 
Aldrich) were detected using iodine staining. 
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Adherence assays. 24-well tissue culture plates (Costar) were seeded with 105 HFF cells 
and allowed to reach confluence in HFF medium [500 ml RPMI with L-glutamine 
(GIBCO), 1 mM Sodium Pyruvate (GIBCO), 10% (w/v) heat inactivated FBS 
(Hyclone)]. The bacteria were serially diluted in HFF medium to determine the inoculum. 
100 μl of the 10-1 dilution was added to each well of HFF cells (MOI 10:1). The plates 
were centrifuged at 1500 rpm for 5 mins then incubated at 33°C for 2 hours. After 
incubation, the wells were washed 3 times with sterile PBS. To collect bacteria, trypsin-
EDTA was added then the contents of each well was collected and plated for quantitative 
culture. Percent adherence of H. ducreyi to HFF cells was determined by calculating the 
ratio of HFF-adhered bacteria to initial CFU.  
 
Phagocytosis assays. Human peripheral blood mononuclear cells (PBMC) were isolated 
from leukopacks obtained from anonymous donors from the Central Indiana Regional 
Blood Center or from blood obtained from normal healthy volunteers. Informed consent 
was obtained in accordance with an IRB-approved protocol. PBMCs were isolated by 
Ficoll-Pacque Plus purification, and CD14+ cells were isolated (Miltenyi Biotech). The 
CD14+ cells were differentiated into MDMs in X-vivo 15 medium (Lonza) supplemented 
with 1% human AB serum (Invitrogen) for 5 days. The MDMs were harvested by 
centrifugation and seeded into 24 well tissue culture plates at 4 x 105 cells per well and 
grown for 24 hours. Bacteria were grown to mid-log and stationary phases and opsonized 
in 100% complement replete normal human serum for 20 mins at room temperature. 
After washing with Hank’s balanced salt solution (HBSS), the MDM were infected with 
bacteria at a multiplicity of infection (MOI) of 10:1. The plates were centrifuged at 1800 
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x g for 5 mins to synchronize infection and were incubated for 30 mins at 35°C in 5% 
CO2. To kill extracellular bacteria, gentamicin (100 μg/ml) was added and incubated for 
30 mins and washed with HBSS. The MDMs were lysed with 0.2% saponin at room 
temperature for 10 mins, and the lysates were quantitatively cultured. The percentage of 
bacterial uptake was calculated as the ratio of bacteria within the lysed MDMs compared 
to the initial CFU. To determine intracellular bacterial survival, the co-cultures were 
incubated in antibiotic-free medium containing 10% fetal bovine serum for an additional 
5 hours and quantitatively cultured. Survival was determined by calculating the ratio of 
recoverable bacteria of co-culture compared to the initial uptake.  
 
Oxidative stress assays. Bacteria were treated with either hydrogen peroxide (H2O2) to 
mimic extracellular oxidative stress or paraquat (Sigma Aldrich) and pyrogallol (Sigma 
Aldrich) to mimic intracellular oxidative stress. Bacteria were exposed to known 
concentrations of each chemical at 33°C in PBS for 1 hour  without shaking and 
quantitatively cultured. For assays using complemented strains, bacterial cells were 
grown to mid-log phase in broth without antibiotics, collected and exposed to oxidative 
stress as described above. Percent survival was calculated as the ratio of recovered 
bacteria to the input CFU. 
 
Heat shock assays. Bacteria were incubated at 37°C for 1 hour in PBS and quantitatively 
cultured. Percent survival was calculated as the ratio of recovered bacteria to the input 
CFU. An untreated control was utilized as a measure of viability for each bacterial strain. 
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Serum bactericidal assay. Bacteria were cultivated for 24 hours on chocolate plates and 
suspended in PBS to an OD of 0.2 (about 108 CFU/ml). Serum from one donor was 
utilized with half being heat inactivated for 35 mins at 56°C. Equal volumes of the 
bacterial suspension and serum were mixed in 96 well plate and the plates were incubated 
for 45 mins at 33°C. Bacterial survival (% survival) was calculated as the ratio between 
surviving bacteria in control wells containing heat-inactivated serum compared to the 
number of surviving bacteria in the complement-replete serum multiplied by 100. 
 
mRNA enrichment. The removal of 23S, 16S, and 5S rRNA from total RNA was 
performed with the Ribo-Zero Magnetic kit for Gram-negative bacteria (Epicentre 
Biotechnologies) by following the manufacturer's instructions. The Agilent 2100 
Bioanalyzer confirmed removal of rRNA from total RNA. 
 
Preparation of RNA-seq libraries and sequencing. The TruSeq Stranded mRNA 
sample preparation kit (Illumina) was used to prepare stranded RNA-Seq libraries by 
following the manufacturer's instructions. Approximately 400 ng of the enriched mRNA 
was fragmented and randomly primed for first-strand cDNA synthesis. Second-strand 
synthesis incorporated dUTP in place of dTTP, which prevents second strand synthesis 
during subsequent amplification and results in a stranded library. The cDNA was end 
repaired, adenylated, and ligated to adapters. The adapter-ligated cDNA library was then 
PCR-enriched. Finally, the enriched RNA-Seq library was validated with the Agilent 
2100 Bioanalyzer and qRT-PCR. Clusters were generated on the cBOT automated 
cluster-generating system with the TruSeq PE Cluster kit (Illumina). Libraries were 
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sequenced with the Illumina HiSeq 2500 sequencer with the TruSeq SBS kit (Illumina) 
for single end sequencing with read lengths of 100 bp in the Biomedical Genomics Core 
facility at Nationwide Children's Hospital (Columbus, OH). Image analysis and base 
calling were performed with the HiSeq Control software and the Real Time Analysis 
software. Demultiplexing was performed with the Illumina CASAVA software. 
 
Sequence mapping and quantification of transcript levels. The sequenced reads were 
mapped to the H. ducreyi 35000HP genome (GenBank accession no. AE017143) with the 
Burrows-Wheeler Alignment tool (147) allowing up to two base mismatches. Reads that 
failed to map to any gene in the chromosome and reads that mapped to multiple locations 
in the genome were removed before quantifying the transcript levels. The total number of 
reads corresponding to the coding region of each gene was determined with the NGSUtils 
suite (148).  
 
Identification of differentially expressed genes. Differential expression of genes across 
all 3 strains and growth phases was determined with edgeR software, a Bioconductor 
package (93). To favor true identification of differentially expressed genes of biological 
significance, we used a pre-specified false-discovery rate of ≤ 0.1 and a 2-fold change as 
a threshold. The differentially expressed genes were functionally classified using the 
annotations and pathway information from the sequenced H. ducreyi genome (Munson 
2004, unpublished), and KEGG (149). We also determined if any biological pathways 
were enriched among the genes differentially expressed in the ∆relA∆spoT and ∆dksA 
mutants compared to 35000HP by using pathway annotations from BioCyc (150). We 
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used the functional annotation-clustering algorithm of the DAVID (Database for 
Annotation, Visualization, and Integrated Discovery) bioinformatics resources 
(http://david.abcc.ncifcrf.gov/) to identify the biological pathways enriched in the 
∆relA∆spoT and ∆dksA mutants relative to 35000HP (151). A pathway was considered 
enriched if the Fisher's exact P value for the cluster was < 0.05, the enrichment score for 
the cluster was greater than 2, and the cluster involved greater than 5% of the total list of 
genes submitted for query (152). 
 
RNA-seq data accession number. The data from these RNA-seq experiments were 
deposited at the NCBI Gene Expression Omnibus (GEO) database 
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE67202. 
 
Statistical analysis. All data are expressed as means ± standard deviations. An adjusted, 
two-sided p value of ≤ 0.05 was considered statistically significant. Stress, bactericidal, 
and macrophage uptake data were analyzed using a mixed-model ANOVA followed by 
Tukey’s honestly significant difference test. qRT-PCR and densitometry data were 
analyzed using Student’s t-test followed by Tukey’s adjustment. For growth curve 
analysis, the data were log-transformed before analysis to correct for the large amount of 
skewness in the distribution. They were then analyzed using a repeated measures (mixed 
model) ANOVA followed by pairwise analysis of the strains at each time point.    
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Chapter III: 
 
Ability to synthesize (p)ppGpp is required for 
Haemophilus ducreyi pathogenesis 
 
Given the fastidious nature of H. ducreyi, inducing the stringent response in vitro 
poses several challenges. Stringent response studies in other bacteria take advantage of 
minimal medium; however, no minimal medium exists for H. ducreyi. Alternatively, drug 
treatments that induce nutrient limiting conditions, such as serine hydroxamate,which 
mimics amino acid starvation, have been used in non-minimal media to activate the 
stringent response in some species. However, it is unclear how H. ducreyi would respond 
to treatment with serine hydroxamate. Moreover, use of drug treatments to induce the 
stringent response in H. ducreyi might prove lethal. Therefore, because chemical 
induction of  the stringent response in wild-type H. ducreyi may introduce confounding 
factors, we used a genetic approach to characterize the stringent response in H. ducreyi.  
 
Conservation of the relA and spoT genes in H. ducreyi clinical strains. We 
conducted a limited strain survey to determine if relA and spoT were conserved across 
multiple clinical isolates. Using primers constructed for detection of the 35000HP relA 
and spoT genes (P3/P4; P5/P6), PCR was performed using DNA isolated from two 
representative strains for each of the 3 groups of H. ducreyi. The representative strains 
were as follows: Class HD183, 82-029362 and I; Class II, 33921 and CIP542; CUD, 
NZS3 and NZS4. Specific details regarding these strains are contained in Table 1. 
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35000HP was included for reference. Amplicons of both relA and spoT were detected in 
all the representative strains indicating that these genes are conserved across multiple 
classes of H. ducreyi (Figure 5). 
 
 
 
 
 
Characterization of the relA and spoT genomic locus in 35000HP. The H. 
ducreyi homolog of relA (HD1185) is in the same orientation and 77 bp upstream of the 
dxr coding region, which is predicted to encode a DXP reductoisomerase (Figure 6A). To 
examine if relA and dxr were in an operon, we conducted RT-PCR on the intergenic 
regions between relA and dxr. Although RT-PCR confirmed that both relA and dxr 
transcripts were present in the cDNA utilized for analysis (data not shown), the data 
suggested that relA was not co-transcribed with dxr (Figure 6B). The H. ducreyi spoT 
homolog (HD1924) is in a putative operon with the gene order recG  rpoZ  spoT  
menB (Figure 6C). The genes recG, rpoZ, and menB are predicted to encode an ATP-
Figure 5.  Survey of H. ducreyi clinical isolates – relA  and spoT. PCR products of relA 
and spoT in clinical H. ducreyi isolates to determine conservation of genes across 
multiple classes.  
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dependent DNA helicase, RNA polymerase omega chain, and dihydroxynaphthoic acid 
synthase, respectively. RT-PCR suggested that spoT is co-transcribed with rpoZ, menB, 
and recG (Figure 6D).   
 
 
 
Construction of relA and relA spoT deletion mutants. To understand the role of 
(p)ppGpp in H. ducreyi pathogenesis, we constructed an unmarked, in-frame relA 
deletion mutant and an unmarked, in-frame relA spoT double deletion mutant. To 
Figure 6. Chromosomal loci containing relA and spoT in H. ducreyi. (A) Genomic 
organization of relA locus in H. ducreyi. The small arrows indicate locations of intergenic 
primers used for RT-PCR analysis. (B) Agarose gel electrophoresis of relA–dxr intergenic 
region amplified by RT-PCR. Lane 1, RNA sample with reverse transcriptase; Lane 2, 
RNA sample without reverse transcriptase control; Lane 3, genomic DNA control; and 
Lane 4, no template control. (C) Genomic organization of spoT locus in H. ducreyi. (D) 
Agarose gel electrophoresis of products amplified by RT-PCR. The intergenic regions of 
recG-rpoZ, rpoZ-spoT, and spoT-menB were examined. Lanes are as in (B). Products 
were of the expected sizes: P7/P8: relA–dxr (515 bp), P9/P10:  recG-rpoZ (541 bp), 
P11/P12: rpoZ-spoT (497 bp), and P13/P14: spoT-menB (222 bp). 
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construct a relA deletion mutant, primers P15/P16 were used to amplify the spec cassette 
flanked by FRT sites from pRSM2832. The coding region of relA was amplified using 
primers P17/P18 and cloned into pCR-XL-TOPO®. The construct, designated pCH1 was 
then electroporated into E. coli DY380. Following induction of the recombinase, the relA 
gene was replaced with the spec cassette with the exception of the start codon and the last 
21 bp of the relA gene. PCR and sequence analyses confirmed the replacement of the 
relA gene with the spec cassette. The strain was then electroporated with pRSM2975. 
PCR and sequence analyses were used to confirm removal of the spec cassette. The final 
mutant was designated 35000HP∆relA.  
Using these methods, a spoT mutant could not be recovered. In other organisms, 
expression of (p)ppGpp synthase in the absence of hydrolase leads to growth arrest and 
cell death; as a result, for many species, spoT is considered an essential gene (138, 153). 
Similar to what has been shown in other species, spoT is likely essential in H. ducreyi 
(138). Therefore, using the relA deletion mutant background, we constructed a relA spoT 
double deletion mutant using the methods described above that primers P19/P20 were 
used to amplify the spec cassette and primers P21/P22 were used to amplify the spoT 
coding and flanking regions, resulting in pCH11 (Table 3). After allele exchange and 
excision of the spec cassette (Figure 7), PCR and sequence analysis confirmed deletion of 
the spoT gene. The double mutant was designated 35000HP∆relA∆spoT. PCR (Figure 7) 
and sequence analyses confirmed that both relA and spoT genes were deleted in 
35000HP∆relA∆spoT with the exception of the start codon and the last 21 bp of the relA 
ORF and the spoT ORF.  
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To determine if deletion of relA or spoT affected the expression of their downstream 
genes dxr and menB, qRT-PCR was performed using primers P29/P30; P31/P32. 
Deletion of relA and spoT did not affect transcription of their downstream genes (data not 
shown).   
 
Deletion of relA and spoT affects the growth and survival of H. ducreyi. Given 
that (p)ppGpp mutants are often growth impaired, we next compared in vitro growth of 
the mutants. In our medium, neither the 35000HP∆relA nor the 35000HP∆relA∆spoT 
mutant exhibited any growth inhibition. In fact, analysis showed that the ∆relA and 
∆relA∆spoT mutants survived better in stationary phase than the parent strain (Figure 8).  
 
Figure 7. Confirmation of deletion of relA and spoT. PCR products using primers 
inside the spoT gene. Primers that recognize the spec  cassette were utilized to 
confirm that the mutant is unmarked. Products were of the expected sizes: P23/24: 
spec int, P25/P26: relA int, and P27/P28: spoT int. 
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Identification of a labeling medium for de novo (p)ppGpp synthesis assay. We 
wanted to determine if deletion of relA and spoT would prevent H. ducreyi from being 
able to synthesize (p)ppGpp. One method for detecting (p)ppGpp in bacteria is incubation 
of the bacteria in nutrient limited media with radioactive phosphate as the only phosphate 
source. Given that there is no defined media for H. ducreyi, we chose to use a modified 
tissue culture medium for our labeling experiments. We first compared the ability of 
35000HP to survive for 2 and 4 hours in the rich media RPMI, DMEM and HBSS, in 
which we could limit the phosphate concentrations. We compared survival of H. ducreyi 
to controls incubated in GC broth and dH2O. We found that H. ducreyi survived at least 
as well in RPMI medium as in GC broth for 4 hours (Figure 9A). We tested growth in 
decreasing concentrations of phosphate in RPMI to determine the lowest concentration of 
sodium phosphate needed to support H. ducreyi growth. We found that at 2 hours, no 
Figure 8.  Growth of 35000HP, 35000HP∆relA, and 35000HP∆relA∆spoT. Measured by CFU 
over 48 hours. The CFU data are geometric means ± SD from three independent experiments. 
*, P ≤ 0.05. 
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survival defect could be detected in 0.0563 mM, 100-fold less phosphate than the RPMI 
standard concentration (Figure 9B).  
 
 
H. ducreyi synthesizes (p)ppGpp and deletion of relA and spoT results in a 
loss of (p)ppGpp synthesis. To determine if H. ducreyi synthesizes (p)ppGpp, 35000HP, 
35000HP∆relA and 35000HP∆relA∆spoT were grown to the mid-log, transition and 
stationary phases, collected, and labeled with KH232PO4. De novo (p)ppGpp synthesis 
was detected using autoradiography. (p)ppGpp synthesis was detected in 35000HP grown 
Figure 9.  Identification of a 32P labeling medium for H. ducreyi. (A) Survival of 35000HP 
in media after 2 and 4 hours culture. (B) Survival of 35000HP in RPMI with varying 
amounts of phosphate. All media contain serum. 
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to the mid-log and transition phases. Maximal synthesis of (p)ppGpp was detected in 
cells harvested from the transition phase (Figure 10). De novo synthesis of (p)ppGpp was 
only variably detected in 35000HP harvested from the stationary phase (data not shown). 
We detected a single species of the alarmone, indicated by the presence of only one spot 
on the TLC plate. We were unable to distinguish between pppGpp and ppGpp species in 
this assay. In both 35000HP∆relA and 35000HP∆relA∆spoT collected from all phases of 
growth, synthesis of (p)ppGpp was not detected. Thus, deletion of relA and deletion of 
relA and spoT resulted in a (p)ppGpp° phenotype in our assay.  
 
 
 
 
Figure 10. De novo synthesis of 
(p)ppGpp in H. ducreyi. Bacteria were 
labeled with KH232PO4 in phosphate-
limited RPMI plus 5% FBS. (p)ppGpp 
was extracted and detected by 
polyethylenimine cellulose thin layer 
chromatography and autoradiography. 
Synthesis of (p)ppGpp was detected in 
cells harvested from mid-log and 
transition phases of growth. Lane 1, 
35000HP; Lane 2, 35000HPΔrelA; and 
Lane 3, 35000HPΔrelAΔspoT. Blot is 
representative of three independent 
experiments. 
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 Given the inability of the 35000HPΔrelA and 35000HPΔrelAΔspoT mutants to 
synthesize (p)ppGpp, we wanted to confirm that the decreased synthesis resulted from 
loss of the enzyme machinery. To this end, we constructed complementation plasmids 
using Gibson Assembly. Fragments containing the cat promoter (P33/P34), the spoT RBS 
and ORF (P35/P36), and the relA RBS and ORF (P37/P38) were included with BamHI 
cut pACYC177 for assembly of the complementation plasmids. Given that unchecked 
synthesis of (p)ppGpp in the absence of spoT is often lethal, in this construct, spoT was 
placed immediately behind the cat promoter to ensure transcription of spoT (Figure 11A). 
Native transcription terminators of the relA gene and putative RBS for each gene were 
also included. The final construct, which contained both the relA and spoT ORF under 
control of the cat promoter, was named pCH30. We also constructed a plasmid which 
only expressed relA, pCH4, by removing spoT from pCH30. Strains containing pCH4 
were slightly growth impaired as they do not express SpoT and thus cannot breakdown 
(p)ppGpp (Figure 11B). qRT-PCR indicated that in the pCH30 complemented strain, 
expression of both relA and spoT was equivalent to wild type levels (Figure 12).  
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Figure 11. Complementation strategy for 35000HPΔrelAΔspoT. (A) Schematic of 
gene organization in plasmid (B) Plasmid maps for constructs pCH4 and pCH30. 
US, native upstream region of target gene. 
Figure 12. Complementation of the relA spoT mutant by pCH30. qRT-PCR of relA and spoT  
in 35000HP (pACYC177), 35000HP∆relA∆spoT (pACYC177), and the complemented strain 
35000HP∆relA∆spoT (pCH30).  
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As shown in Figure 10, 35000HP synthesized (p)ppGpp readily in transition 
phase but not the 35000HP∆relA nor the 35000HP∆relA∆spoT mutants. Therefore, we 
next determined if we could complement the loss of (p)ppGpp synthesis in the null 
mutants. 35000HP(pACYC177) and 35000HP∆relA∆spoT(pACYC177) recapitulated the 
phenotypes of the non-plasmid containing strains (Figure 13). When the ∆relA∆spoT 
mutant was complemented with only relA (pCH4), (p)ppGpp synthesis was restored 
(Figure 13). Thus, pCH4 can complement for loss of (p)ppGpp in 35000HP∆relA∆spoT. 
However, complementation with pCH30, which contained both genes did not show a spot 
correlating with (p)ppGpp. We thought that in the double complemented mutant, 
(p)ppGpp is likely being rapidly synthesized by RelA and degraded as rapidly by SpoT 
into the breakdown products depicted in Figure 1. As neither relA nor spoT were 
regulated by their native promoters, the stoichiochemistry of the two enzymes likely does 
not reflect natural conditions. Still, taken together, this showed that pCH30 restores 
expression levels of relA and spoT to wild type levels and suggests that SpoT is 
functional in vitro.  
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relA and spoT contribute to H. ducreyi virulence in human volunteers. To 
determine if RelA and SpoT contribute to virulence in humans, we inoculated four groups 
of volunteers with 35000HP and with the 35000HP∆relA∆spoT mutant. In the first 
iteration, one volunteer was inoculated at three sites with an EDD of 157 CFU of 
35000HP and three sites with an EDD of 24, 48, and 96 CFU of 35000HP∆relA∆spoT. In 
the second iteration, three volunteers were each inoculated at three sites with an EDD of 
74 CFU of 35000HP and with ∆relA∆spoT at three sites with EDDs of 33, 66, and 132 
CFU. In the third iteration, one volunteer was inoculated with an EDD of 49 CFU of 
35000HP at three sites and at EDDs of 21, 41, and 81 CFU of ∆relA∆spoT at three sites. 
In the final iteration, one volunteer was inoculated with an EDD of 81 CFU of 35000HP 
at three sites and at three sites with EDDs of 35, 71, and 141 of ∆relA∆spoT. Overall, 
Figure 13. De novo synthesis of 
(p)ppGpp with complemented strains. 
Bacteria were labeled with KH232PO4 in 
phosphate-limited RPMI plus 5% FBS. 
(p)ppGpp was extracted and detected by 
polyethylenimine cellulose thin layer 
chromatography and autoradiography. 
Synthesis of (p)ppGpp was detected in 
cells harvested from mid-log and 
transition phases of growth. Lane 1, 
35000HP(pACYC177); Lane 2, 
35000HPΔrelAΔspoT(pACYC177); 
Lane 3, 35000HPΔrelAΔspoT(pCH4); 
and Lane 4, 35000HPΔrelAΔspoT 
(pCH30). Blot is representative of three 
independent experiments. 
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papules formed at 94% (95% CI, 84.5 - 99.9%) of the parent-inoculated sites and at 94% 
(95% CI, 84.5 - 99.9%) of the mutant inoculated sites (P = 1.0) (Table 5). After 24 hours 
of infection, the mean surface area of the papules was 23.7 ± 24.4 mm2 at parent sites and 
18.2 ± 22.4 mm2 at mutant sites (P = 0.36). Pustules formed at 72.2% (95% CI, 48.3 – 
96.2%) of parent sites and 27.8% (95% CI, 0.1-56.2%) of mutant sites (P = <0.0001).  
Thus, the relA spoT mutant was partially attenuated for pustule formation in humans. 
At least one positive surface culture for H. ducreyi was obtained during follow-up 
visits from 39.9% of the parent inoculation sites and 16.7% of the mutant inoculation 
sites. All colonies recovered from the surface cultures of the parent sites (n = 280) and 
mutant sites (n = 32) were tested for the presence of relA, spoT, and dnaE sequences by 
colony hybridization. The dnaE probe hybridized to colonies from both parent and 
mutant sites, while the relA and spoT probes only bound to colonies from the parent sites. 
All 3 biopsy specimens from parent sites yielded H. ducreyi, and all 3 biopsy specimens 
from mutant sites yielded H. ducreyi. The dnaE probe hybridized to both parent (n = 108) 
and mutant (n = 101) colonies obtained from the biopsies. When the inocula were tested, 
the dnaE probe hybridized to all the colonies tested from both parent (n = 144) and 
mutant (n = 140) colonies, while the relA and spoT probes only hybridized to the parent 
inoculated colonies. There was no evidence of cross-contamination between the mutant 
and parent inoculation sites.  
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Table 4. Response to inoculation of live H. ducreyi strains – parent vs. ∆relA∆spoT 
      
Final outcome of 
papules 
Volunteer 
(gender)a 
 Observation 
period 
(days) 
Strainb Dose (CFU)c 
No. of 
initial 
papules 
No. 
resolved 
No. of 
pustules 
433 (F) 7 P 157 3 2 1 
  M 24-96 3 3 0 
436 (F) 8 P 74 3  3 
  M 33-132 3 2 1 
437 (F) 7 P 74 3  3 
  M 33-132 2 1 1 
438 (M) 7 P 74 3  3 
  M 33-132 3  3 
439 (M) 7 P 49 3 1 2 
  M 21-81 3 3 0 
440 (M) 9 P 81 2 1 1 
  M 35-141 3 2 0 
aVolunteer 433 was inoculated in the first iteration. Volunteers 436, 437, and 438 were 
inoculated in the second iteration. Volunteer 440 was inoculated in the third iteration. 
Volunteer 439 was inoculated in the fourth iteration. M, male; F, female.  
bP, Parent strain 35000HP; M, mutant strain 35000HPΔrelAΔspoT.                                        
cDoses inoculated at 3 sites, except 24-96, one dose each of 24, 48, and 96 CFU; 33-132, 
one dose each of 33, 66 and 132 CFU; 21-81, one dose each of 21, 41, and 81 CFU; 35-
141, one dose each of 35, 71, and 141 CFU. 
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Three volunteers (436, 437, and 438) developed pustules at both mutant and 
parent sites. For each subject, one parent site and one mutant site were biopsied and 
stained with hematoxylin-eosin and anti-CD3 antibodies as previously described (154). 
All samples contained micropustules in the epidermis and dermal CD3 cells (data not 
shown). Histopathologically, pustules formed at mutant sites were indistinguishable from 
pustules formed at parent sites. 
 
Deletion of relA alters the OMP profile of H. ducreyi. We investigated if 
deletion of relA and spoT affected expression of outer membrane components of H 
ducreyi. OMP and LOS were prepared from 35000HP, 35000HPΔrelA and 
35000HPΔrelAΔspoT harvested from mid-log phase. 35000HP, 35000HPΔrelA, and 
35000HPΔrelAΔspoT had identical LOS profiles (Figure 14).  
 
 
 
 
 
Figure 14: LOS Profile of 35000HP, 35000HPΔrelA and 35000HPΔrelAΔspoT.                                                                            
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Analysis of OMP showed increased expression of a band that migrates between 
40 - 45 kDa in both 35000HPΔrelA (data not shown) and 35000HPΔrelAΔspoT 
compared to the parent strain (Figure 15A). Tandem mass spectrometry experiments 
performed on the excised band identified 19 potential proteins, with predicted molecular 
weights between 41-49 kDa (Table 6). The protein with the highest overall score was 
OmpP2B, a putative porin previously described in H. ducreyi (155). Western blot 
analysis with an OmpP2B-specific antibody confirmed that the relA spoT mutant 
expressed more OmpP2B than the parent strain (Figure 15B).  
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Figure 15: OMP expression of 35000HP and 35000HPΔrelAΔspoT                                                                            
harvested from mid-log phase (A) Purified outer membranes were analyzed by SDS-
PAGE and Coomassie staining. Arrows indicate protein bands selected for further 
analysis; open arrow, OmpP2B; filled arrow, DsrA. Lane 1, 35000HP; and Lane 2, 
35000HPΔrelAΔspoT. (B) Western blot analysis of purified outer membrane proteins of 
35000HP and 35000HP∆relA∆spoT. Lysates were probed with OmpP2B specific 
antibody. (C) Western blot analysis of purified outer membrane proteins of 35000HP, 
35000HP∆relA∆spoT and the dsrA mutant, FX517. Lysates were probed with DsrA 
specific antibody. Anti-PAL MAb 3B9 was used to verify equivalent loading. Lane 1, 2 
as in (B); Lane 3, FX517. 
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Analysis of OMP profiles showed that a band that migrates at the apparent 
molecular weight of DsrA, the major determinant of serum resistance, appeared to be 
decreased in both 35000HPΔrelA (data not shown) and 35000HPΔrelAΔspoT relative to 
35000HP (Figure 15A). By Western blot, the level of expression of DsrA between in 
35000HPΔrelAΔspoT was somewhat reduced compared to 35000HP (Figure 15C). 
 
 
 
 
 
Figure 16: Effect of relA and spoT deletion on the expression of DsrA. (A) Western blot 
analysis of whole cell lysates of 35000HP, 35000HP∆relA, and 35000HP∆relA∆spoT 
harvested from mid-log, transition and stationary phases of growth. Lysates were probed 
with DsrA antibody. Lane 1, 35000HP; Lane 2, 35000HPΔrelA; and Lane 3, 
35000HPΔrelAΔspoT. Blot is representative of three independent experiments. (B) H. 
ducreyi sensitivity to complement-replete human serum. Percent survival of 35000HP, 
35000HPΔrelAΔspoT, and dsrA mutant strain FX517 in normal human serum (NHS). 
Survival was calculated as [(geometric mean CFU in NHS/geometric mean CFU in heat-
inactivated NHS) × 100]. Data are means ± SD of three independent experiments. All 
strains were compared to 35000HP. 
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We harvested cells from the 3 strains collected at the mid-log, transition and 
stationary phases of growth; Western blot and densitometry analysis showed that 
expression of DsrA was significantly reduced in both the single (P = 0.05) and double 
mutants (P = 0.043) compared to the parent in cells collected at mid-log phase but not in 
cells collected in the transition or stationary phases (all P values > 0.24) (Figure 16A). In 
bactericidal assays using 50% normal human serum and colonies harvested from 
chocolate agar plates, 35000HPΔrelAΔspoT was as resistant to killing as the parent strain 
(Figure 16B). Thus, the reduction in DsrA expression in the mutant during mid-log phase 
may not be biologically significant. 
 
RelA and SpoT do not contribute to heat stress resistance. In other organisms, 
(p)ppGpp induces expression of genes critical for responses to heat shock such as rpoH 
(156-158). H. ducreyi 35000HP grows optimally at 33°C (13). To determine if relA and 
spoT had a role in regulating responses to heat shock, we compared the survival of 
35000HP∆relA and 35000HP∆relA∆spoT relative to 35000HP after incubation at 37°C 
for 1 hour. Percent survival rates were not significantly different among the strains 
(Figure 17). Thus, RelA and SpoT did not contribute to H. ducreyi survival following 
heat shock. 
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Loss of (p)ppGpp decreased phagocytic uptake of mid-log phase grown H. 
ducreyi. During both natural and experimental infection, H. ducreyi associates with 
neutrophils and macrophages but remains extracellular (50, 159). LspB is required for the 
secretion of LspA1 and LspA2, which are responsible for resistance to phagocytosis (61, 
62). lspB  and lspA2 are co-transcribed; LspB is maximally expressed and LspA1 and 
LspA2 are maximally secreted during stationary phase. To determine the role of 
(p)ppGpp in resistance to phagocytosis, we compared the uptake of 35000HP, 
35000HP∆relA and 35000HP∆relA∆spoT cells grown to mid-log and stationary phase by 
primary human macrophages. No differences were found for the uptake of cells harvested 
at stationary phase (Figure 18A). However, compared to the parent, a significant 
Figure 17: Response of 35000HPΔrelA and 35000HPΔrelAΔspoT to heat stress at 
37°C. Data are means ± SD of three independent experiments. All strains we 
compared to survival at 33°C. 
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reduction in the uptake of the ∆relA∆spoT mutant (P = 0.0076) and trended towards 
reduction in the uptake of the ∆relA mutant (P = 0.052) was shown for cells harvested at 
mid-log phase. 
 
 
 
 
Figure 18: Uptake by and survival in macrophages. (A) Percent uptake of 35000HP, 
35000HP∆relA, and 35000HP∆relA∆spoT by human macrophages. MDM were infected 
with opsonized H. ducreyi at an MOI of 10:1. After 30 minutes of incubation, 
gentamicin was added to kill extracellular bacteria. The percent uptake was calculated 
as [(geometric mean CFU of gentamicin-protected bacteria at 1 hour/ geometric mean 
CFU of input bacteria) x 100]. Data are mean ± SD from five independent donors. (B) 
Survival was calculated as  [(geometric mean CFU of after 6 hours co-culture/ 
geometric mean CFU of gentamicin-protected bacteria at 1 hour) x 100]. 
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RelA and SpoT are important for resistance to oxidative stress. (p)ppGpp 
expression is often critical for survival of bacteria during oxidative stress (160-162). We 
compared the survival of 35000HP, 35000HP∆relA, and 35000HP∆relA∆spoT after 
incubation with hydrogen peroxide. When mid-log or stationary phase bacteria were 
incubated with 0.2 mM or 2 mM H2O2, both the relA and relA spoT mutants survived at 
significantly lower levels than the parent strain (Figure 19A). Complementation of the 
relA spoT mutant restored resistance to both 0.2 mM and 2 mM H2O2 (Figure 19B).  
 
 
Figure 19: H. ducreyi survival after oxidative stress at mid-log and stationary phase. (A) 
Percent survival of 35000HP, 35000HP∆relA, and 35000HP∆relA∆spoT following incubation 
with 0.2 mM or 2 mM H2O2 for 1 hour. (B) Percent survival of mid-log phase 35000HP 
(pACYC177), 35000HP∆relA∆spoT (pACYC177), and the complemented strain 
35000HP∆relA∆spoT (pCH30) following incubation with 0.2 mM or 2 mM H2O2 for 1 hour. 
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When bacteria in either mid-log or stationary phase were incubated with 0.2 mM 
or 2 mM paraquat, the relA and relA spoT mutants survived at significantly lower levels 
than the parent strain (Figure 20A). Complementation with relA spoT was able to restore 
statistically significant resistance to 2 mM paraquat (Figure 20B). Therefore, RelA and 
SpoT contribute to H. ducreyi survival to oxidative stress generated by paraquat. 
 
 
 
Figure 20: Survival in paraquat-induced oxidative stress. (A) Percent survival of 35000HP, 
35000HP∆relA, and 35000HP∆relA∆spoT following 1 hour incubation with 0.2 mM or 2 mM 
paraquat. (B) Percent survival of mid-log phase 35000HP (pACYC177), 
35000HP∆relA∆spoT (pACYC177), and 35000HP∆relA∆spoT (pCH30) following incubation 
with 0.2 mM or 2 mM paraquat for 1 hour. All percent survivals were calculated as 
[(geometric mean CFU after treatment/ geometric mean before treatment) x 100]. The data 
are mean ± SD from four independent experiments. *, P ≤ 0.05. 
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Given that the relA spoT mutant was more sensitive to oxidative stress, we 
investigated if (p)ppGpp regulated the expression of genes that encode putative oxidative 
stress responsive proteins. The genes oxyR and sodC encode the hydrogen peroxide- 
inducible gene activator and periplasmic Cu-Zn superoxide dismutase, respectively. 
Compared to the parent, transcript levels of both oxyR and sodC were unchanged in the 
35000HP∆relA∆spoT mutant (data not shown). Thus, the mechanism of (p)ppGpp-
mediated resistance to oxidative stress is unclear.  
 
Deletion of relA and spoT affects expression of dksA. DksA is an important 
cofactor of (p)ppGpp that helps stabilize the interaction of (p)ppGpp with RNA 
polymerase (106). As overexpression of dksA has been shown to compensate for the loss 
of (p)ppGpp in other bacteria, we determined if loss of (p)ppGpp affected transcript 
levels of dksA. qRT-PCR showed that compared to wild type strain results, dksA was 
significantly upregulated in the 35000HPΔrelAΔspoT mutant harvested from the mid-log 
phase (4.31 ± 0.87, P = 0.0025) and the transition phase (5.33 ± 2.01, P = 0.03) of 
growth. No difference in the levels of dksA expression was found between the 
35000HPΔrelAΔspoT and 35000HP strains grown to the stationary phase (1.69 ±1.16). 
Thus, loss of relA and spoT may be in part compensated by upregulation of dksA. 
 
DksA may compensate for loss of (p)ppGpp in resistance to oxidative stress. 
In E. coli, dksA overexpression can compensate for loss of (p)ppGpp (134, 163). We 
therefore tested whether overexpression of dksA could compensate for loss of (p)ppGpp. 
To this end, we generated 35000HPΔrelAΔspoT(pCH24), which overexpresses dksA but 
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does not synthesize (p)ppGpp. We used strain 35000HPΔrelAΔspoT(pCH30), the 
ΔrelAΔspoT complemented strain, as a control for the assay (164). Sensitivity of 
35000HPΔrelAΔspoT(pACYC177) to 2 mM hydrogen peroxide was significantly 
restored in both 35000HPΔrelAΔspoT(pCH30) (P= 0.0002) and 
35000HPΔrelAΔspoT(pCH24) (P= 0.0029) (Figure 21). Therefore, DksA overexpression 
may partially compensate for the loss of (p)ppGpp in resistance to oxidative stress in 
vitro. 
 
 
 
 
Figure 21. Complementation of the ∆relA∆spoT mutant in oxidative stress. Percent survival of 
mid-log phase 35000HP (pACYC177), 35000HP∆relA∆spoT (pACYC177), and the 
complementation strains 35000HP∆relA∆spoT (pCH30) and 35000HP∆relA∆spoT (pCH24) 
following incubation with 0.2 mM or 2 mM H2O2 for 1 hour. All percent survivals were 
calculated as [(geometric mean CFU after treatment/ geometric mean before treatment) x 100]. 
The data are mean ± SD from five independent experiments. *, P ≤ 0.05. 
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In summary, our findings suggest an important role for (p)ppGpp in H. ducreyi 
virulence in humans. Our findings also highlight the underappreciated roles of (p)ppGpp 
in regulating phenotypes associated with exponential growth. Given that upregulation of 
dksA may partially compensate for the loss of ppGpp in vivo, we next determined the role 
of DksA in H. ducreyi pathogenesis.  
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Chapter IV: 
 
A DksA mutant is partially attenuated in humans due to alteration  
of multiple virulence-associated phenotypes 
 
Given that overproduction of DksA is known to phenotypically compensate for 
lack of (p)ppGpp in E. coli and may compensate for loss of (p)ppGpp in H. ducreyi, we 
next characterized a dksA deletion mutant (134). 
 
Characterization of the dksA genomic locus. The H. ducreyi homolog of dksA 
(HD0603) is in a putative operon with the gene order tbpA  dksA  pcnB  folK 
(Figure 22A). The genes tbpA, pcnB, and folK are predicted to encode a thiamin ABC 
transporter, poly (A) polymerase, and 7,8-dihydro-6-hydroxymethylpterin-
pyrophosphokinase, respectively. RT-PCR analysis indicated that dksA is co-transcribed 
with tpbA, pcnB, and folk (Figure 22B) 
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Conservation of the dksA gene in H. ducreyi clinical strains. We conducted a 
limited strain survey to determine if dksA was conserved across clinical isolates of H. 
ducreyi. Using primers constructed for detection of the 35000HP dksA gene (P45/P46), 
PCR was performed on two representative strains from each of the 3 classes. The 
representative strains were the following: Class HD183, 82-029362 and I; Class II, 33921 
and CIP542; CUD, NZS3 and NZS4. Specific details regarding these strains are 
contained in Table 1. Analysis indicated that the dksA gene is detected in all the 
representative strains indicating that this gene is are conserved in H. ducreyi (Figure 23). 
Figure 22. Chromosomal locus containing dksA in H. ducreyi. (A) Genomic organization of 
dksA locus in H. ducreyi. The small arrows indicate locations of intergenic primers used for 
RT-PCR analysis. (B) Agarose gel electrophoresis of products amplified by RT-PCR. The 
intergenic regions of tbpA-dksA, dksA-pcnB, and pcnB-folK were examined. Lane 1, RNA 
sample with reverse transcriptase; Lane 2, RNA sample without reverse transcriptase control; 
Lane 3, genomic DNA control; and Lane 4, no template control. Products were of the 
expected sizes: tbpA-dksA (197 bp), dksA-pcnB (332 bp), and pcnB-folK (371 bp). 
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dksA contributes to H. ducreyi virulence in human volunteers. To determine if 
DksA contributes to virulence in humans, we constructed an unmarked, in-frame dksA 
deletion mutant. The mutant was constructed as previously described except that primers 
P47/P48 were used to amplify the spec cassette and the dksA ORF was amplified using 
primers P49/P50. The final mutant was designated 35000HP∆dksA.  
 We next confirmed that 35000HP∆dksA was in fact a dksA deletion mutant using 
PCR (Figure 24). PCR confirmed a size shift indicating that the dksA gene has been 
removed. PCR using primers interior to the dksA gene confirmed that dksA has been 
deleted in the mutant (Figure 24). Sequencing confirmed that the mutant was correct.  
Figure 23.  Strain survey of H. ducreyi clinical isolates - dksA. PCR products of dksA in 
clinical H. ducreyi isolates to determine conservation of genes across multiple classes. 
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Deletion of dksA does not alter OMP or LOS profiles of H. ducreyi. We 
investigated if deletion of dksA affected expression of outer membrane components of H 
ducreyi. OMPs and LOS were prepared from 35000HP and 35000HPΔdksA harvested 
from mid-log phase. 35000HP and 35000HPΔdksA had identical LOS profiles indicating 
that no qualitative differences in LOS exist between the mutant and the wild type strain 
(Figure 25).  
 
Figure 24.  Confirmation of deletion of dksA. PCR products using primers both outside and 
inside the dksA gene. Products were of the expected sizes: P49/50, exterior dskA and 
P45/P46, dksA int.  
Figure 25. LOS Profile of 35000HP and 35000HPΔdksA. 
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As expected, the dksA mutant has no qualitative differences in protein expression 
in the outer membrane (Figure 26). Analysis of the OMP indicated that 35000HPΔdksA 
expresses DsrA at similar levels to 35000HP.    
 
  
 
 
 
 
 
Human challenge with 35000HP∆dksA. We inoculated volunteers in three 
iterations with 35000HP and with 35000HP∆dksA. In the first iteration, three volunteers 
were inoculated at three sites with an EDD of 82 CFU of 35000HP and at 1 site each with 
an EDD of 52, 104, and 207 CFU of 35000HP∆dksA. In the second iteration, two 
volunteers were each inoculated at three sites with an EDD of 150 CFU of 35000HP and 
with ∆dksA at three sites with EDDs of 87, 174, and 348 CFU. In the third iteration, two 
volunteers were inoculated with an EDD of 77 CFU of 35000HP at three sites and an 
Figure 26: OMP expression of 
35000HP and 35000HPΔdksA.  
Purified outer membranes were 
analyzed by SDS-PAGE and 
Coomassie staining. 
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EDD of 137 CFU of ∆dksA at three sites. Overall, papules formed at 90.5% (95% CI, 
79.3 - 99.9%) of the parent-inoculated sites and at 81.0% (95% CI, 63.0 - 98.9%) of the 
mutant inoculated sites (P = .094) (Table 6). After 24 hours of infection, the mean surface 
area of the papules was 9.1 ± 9.2 mm2 at parent sites and 4.6 ± 6.9 mm2 at mutant sites (P 
= 0.012). Pustules formed at 42.9% (95% CI, 14.2 – 71.5%) of parent sites and 14.3% 
(95% CI, 2.1-26.5%) of mutant sites (P = 0.043). Thus, the ΔdksA mutant was partially 
attenuated for pustule formation in humans.  
Three volunteers (455, 457, and 459) developed pustules at both mutant and 
parent sites. For each subject, one parent site and one mutant site were biopsied, divided 
in half and semi-quantitatively cultured or stained with hematoxylin-eosin and anti-CD3 
antibodies as previously described (154). All samples contained micropustules in the 
epidermis and dermal CD3 cells (data not shown). Histopathologically, pustules formed 
at mutant sites were indistinguishable from pustules formed at parent sites.  
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Table 6. Response to inoculation of live H. ducreyi strains – parent vs. ∆dksA 
  Final outcome of papules 
Volunteer 
(gender)a 
 Observation 
period (days) Strain
b Dose (CFU)c 
No. of 
initial 
papules 
No. of 
pustules Resolved 
454 (F) 7 
P 82 2 0 2 
M 52-207 2 0 2 
455 (M) 9 
P 82 3 1 2 
M 52-207 3 1 2 
456 (F) 5 
P 82 3 0 3 
M 52-207 2 0 2 
457 (F) 7 
P 150 3 3 0 
M 87-348 3 1 2 
458 (F) 5 
P 150 2 0 2 
M 87-348 1 0 1 
459 (M) 8 
P 77 3 1 2 
M 137 3 1 2 
460 (F) 12 
P 77 3 3 0 
M 137 3 0 3 
aVolunteers 454, 455, and 456 were inoculated in the first iteration. Volunteers 457 and 
458 were inoculated in the second iteration. Volunteers 459 and 460 were inoculated in 
the third iteration; M, male; F, female        
bP, Parent strain 35000HP; M, mutant strain 35000HPΔdksA.         
cDoses inoculated at 3 sites, except 52-207, one dose each of 52, 104, and 207 CFU; 87-
348, one dose each of 87, 174 and 348 CFU.                                         
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All colonies recovered from the inocula, surface cultures and biopsies were tested 
for the presence of dksA and dnaE sequences by colony hybridization. The dnaE probe 
hybridized to all the colonies tested from both parent (n = 108) and mutant (n = 107) 
inocula, while the dksA probe only hybridized to colonies from the parent inocula. At 
least one positive surface culture for H. ducreyi was obtained during follow-up visits 
from 19.5% of the parent inoculation sites and 4.8% of the mutant inoculation sites. The 
dnaE probe hybridized to colonies from both parent (n = 106) and mutant (n = 29) 
inoculated sites, while the dksA probe only bound to colonies from the parent sites. All 3 
paired biopsies of mutant and parent pustules yielded H. ducreyi. The dnaE probe 
hybridized to all of both parent (n = 107) and mutant (n = 69) colonies obtained from the 
biopsies, while the dksA probe only hybridized to colonies obtained from the parent 
biopsies. There was no evidence of cross-contamination between the inocula and mutant 
and parent inoculation sites.  
 
In vitro characterization of the dksA mutant. The virulence of H. ducreyi has 
been correlated with resistance to serum-mediated killing, phagocytosis, and oxidative 
stress as well as adherence to human foreskin fibroblasts. H. ducreyi mutants with defects 
in the above in vitro phenotypes are partially or fully attenuated in the human challenge 
model. The level of expression of DsrA, the major determinant of serum resistance, in 
35000HPΔdksA was no different than that of 35000HP (Figure 26). To determine if the 
dksA mutant was sensitive to serum-mediated killing, a bactericidal assay was performed. 
35000HPΔdksA was as resistant to 50% normal human serum as the parent strain (Figure 
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27); both the parent and the dksA mutant were significantly more resistant to serum 
killing than the serum sensitive dsrA mutant, FX517 (Figure 27).  
 
 
 
To determine the role of DksA in resistance to phagocytosis, we compared the 
uptake and intracellular survival of cells collected at mid-log and stationary phase by 
primary human macrophages. No differences were found in the uptake of the dksA 
mutant harvested at mid-log phase compared to the parent (Figure 28A). However, there 
was a trend for the dksA mutant to be taken up at a higher rate than the parent when the 
bacteria were harvested at stationary phase (P = 0.055).  
Figure 27. H. ducreyi sensitivity to complement-replete human serum. Percent survival of 
35000HP, 35000HPΔdksA, and dsrA mutant strain FX517 in normal human serum (NHS). 
Survival was calculated as [(geometric mean CFU in NHS/geometric mean CFU in heat-
inactivated NHS) × 100]. Data are means ± SD of five independent experiments. All strains 
were compared to 35000HP. *, P ≤ 0.05. 
 
 
82 
 
 
 
No differences were found for the intracellular survival of the mutant compare to 
the parent harvested at mid-log phase (Figure 28B). However, a significant reduction in 
the intracellular survival of the dksA mutant (P = 0.023) was shown for cells harvested at 
stationary phase. Thus, DksA plays a role in resistance to phagocytosis and intracellular 
survival for stationary phase cells. 
Figure 28. Uptake of H. ducreyi by and survival within human macrophages. (A) Percent 
uptake of 35000HP and 35000HP∆dksA by human macrophages. Primary human CD14+ 
cells were differentiated into monocyte-derived macrophages (MDM). MDM were 
infected with opsonized H. ducreyi at an MOI of 10:1. After 30 minutes of incubation, 
gentamicin was added to kill extracellular bacteria. The percent uptake was calculated as 
[(geometric mean CFU of gentamicin-protected bacteria at 1 hour/ geometric mean CFU 
of input bacteria) x 100]. Data are mean ± SD from five independent donors. *, P ≤ 0.05.  
To determine survival, MDMs were incubated an additional 6 hours and bacteria were 
collected. Survival after uptake was calculated as [(geometric mean CFU of bacteria 
collected after 6 hours / geometric mean CFU of gentamicin- protected bacteria at 1 hour) 
x 100]. Data are mean ± SD from 5 independent donors. 
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The reduced survival of H. ducreyi within macrophages is linked to increased 
sensitivity to oxidative stress (94, 164). We thus compared the survival of 35000HP and 
35000HP∆dksA after incubation with hydrogen peroxide. When stationary phase bacteria 
were incubated with 0.2 mM or 2 mM H2O2, the dksA mutant survived significantly less 
than the parent strain (P= 0.023 and P= 0.0002, respectively) (Figure 29A). For cells 
Figure 29. Survival of the dksA mutant after oxidative stress. (A) Percent survival of 35000HP 
and 35000HP∆dksA following incubation with 0.2 mM or 2 mM H2O2 for 1 hour. (B) Percent 
survival of 35000HP (pACYC177), 35000HP∆dksA (pACYC177), and the complemented strain 
35000HP∆dksA (pCH24) following incubation with 0.2 mM or 2 mM H2O2 for 1 hour. All 
percent survivals were calculated as [(geometric mean CFU after treatment/ geometric mean 
before treatment) x 100]. The data are mean ± SD from five independent experiments. *, P ≤ 
0.05. 
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grown to mid-log phase, the dksA mutant survived significantly less than the parent at 2 
mM H2O2 (P= 0.0005) with a trend towards significance at 0.2 mM (P= 0.052).  
To confirm that the increased sensitivity to H2O2 seen in the ∆dksA mutant was 
due to deletion of dksA, we constructed the dksA complement plasmid pCH24. Primers 
P51/P52 were used to amplify the dksA ORF. The fragment was ligated into plasmid 
pCH31, a plasmid containing a cat promoter with NdeI sites for gene insertion. 
Expression of pCH24 in the dksA mutant restored wild type levels of dksA (Figure 30). 
However, as the gene is under control of a constitutive promoter and not its native 
promoter, any expression that occurs in the complemented strain will be independent of 
native regulation. 
 
 
 
Figure 30. Complementation of the dksA mutant by pCH24. qRT-PCR of dksA in 
35000HP (pACYC177), 35000HP∆dksA (pACYC177), and the complemented strain 
35000HP∆dksA (pCH24).  
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We next used the complemented dksA strain in our oxidative sensitivity assay. In 
cells harvested at mid-log phase, 35000HP∆dksA (pACYC177) survived significantly 
less well than 35000HP (pACYC177) at both 0.2 (P = 0.044) and 2 mM (P < 0.0001) 
(Figure 29B). Complementation of the dksA mutant in trans with plasmid pCH24 
restored resistance to 2 mM H2O2 (P = <0.0001) but not 0.2 mM (Figure 29B). 
Therefore, DksA contributes to H. ducreyi survival after exposure to H2O2. 
Adherence to human foreskin fibroblasts mediated by the Flp-Tad operon is 
associated with virulence in the human challenge model (70, 72). Similarly, a UPEC dksA 
mutant is impaired in its ability to adhere to eukaryotic cells, perhaps due to 
downregulation of Type 1 fimbriae expression (134). Other studies in E. coli and EHEC 
also indicate that dksA mutants tend to have decreased attachment as well as decreased 
expression of genes involved in the regulation of attachment (163, 165). Therefore, we 
compared the adherence of 35000HP, 35000HPΔdksA, and 35000HPΔflp1-3 to HFF cells 
at both mid-log and stationary phase. For cells harvested at mid-log phase, the ΔdksA 
mutant attached to HFF cells at significantly lower levels (46.9 ± 9.6 %) than did the 
parent (116.6 ± 25.2 %) (P = 0.0004) but tended to attach to HFF cells better than the 
Δflp1-3 mutant (17.6 ± 10.7 %)  (P= 0.052) (Figure 31). In cells harvested from 
stationary phase, both the ΔdksA mutant (15.6 ± 8.5 %) and the Δflp1-3 mutant (10.7 ± 
4.3 %) exhibited significantly reduced attachment compared to the parent strain (95.9 ± 
10.2 %) (P = <0.0001) (Figure 31). 
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The decreased attachment of the dksA mutant could have resulted from decreased 
secretion of the Flps by the Flp-Tad secretion system, decreased expression of the Flp 
proteins, or decreased expression of co-factor(s) required for Flp-dependent adherence. 
Compared to the parent, the transcript levels of flp1 and tadA were unchanged in the dksA 
mutant (data not shown). To determine if the decreased adherence of the dksA mutant 
harvested at stationary phase was a result of decreased expression or altered localization 
of the Flp proteins, we examined the expression of Flp1/2 in whole cell lysates and outer 
membranes by Western blot. The tadA mutant (35000HP.400) and the Δflp1-3 mutant 
were used as controls for the assay. While the Δflp1-3 mutant expressed no Flp proteins, 
Figure 31. Adherence of the dksA  mutant to HFF cells. Percent adherence of 35000HP, 
35000HPΔdksA and 35000HPΔflp1-3 to HFF cells calculated as follows: (geometric 
mean CFU of HFF-adherent bacteria/geometric mean CFU of initial bacteria added per 
well) × 100. The data represent the means ± SD from 5 independent experiments. *, P ≤ 
0.05.  
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the tadA mutant expressed the Flps but did not secrete the proteins to the outer 
membrane. Flp expression in whole cells and outer membranes were comparable between 
wild type and the dksA mutant (Figure 32). Thus, the adherence defect in the dksA mutant 
cannot be attributed to decreased expression or lack of localization of the Flp proteins to 
the outer membrane, suggesting that DksA regulates the expression of co-factor(s) that 
are required for Flp-mediated adherence. 
 
 
 
 
 
 
 
 
Figure 32. Expression of the Flp1/2 protein in dksA mutant OMP and WCL. Lane 1, 
35000HP; Lane 2, 35000HP∆dksA; Lane 3, 35000HP.400, the tad mutant; and Lane 
4, 35000HP∆flp1-3, the flp mutant. Samples were probed with Flp1/2 antibody. MAb 
3B9 was used to verify equivalent loading. Data is representative of 4 independent 
experiments. 
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Overall, in this chapter we showed that in addition to (p)ppGpp, DksA contributes 
to the virulence of Haemophilus ducreyi in humans and plays an important role in 
pathogenesis. This study, when taken together with the (p)ppGpp mutant data, 
underscores the potentially distinct roles DksA and (p)ppGpp play in regulation of H. 
ducreyi virulence. Given the similarities of the two mutants, comparison of the two 
regulons would help to elucidate the overlapping and independent functions of (p)ppGpp 
and DksA in H. ducreyi. Therefore, we next analyzed the transcriptomes to better 
understand the intersecting and diverging roles of the two regulators in H. ducreyi 
virulence.   
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Chapter V: 
 
Loss of (p)ppGpp or DksA dysregulates multiple virulence 
 determinants as identified by RNA-seq 
 
Loss of dksA and (p)ppGpp can have unique, overlapping, and pleiotropic effects 
on transcription. To better understand their respective contributions to pathogenesis, we 
next determined the effect of DksA and (p)ppGpp deficiency on gene expression.  
 
DksA and (p)ppGpp deficient transcriptomes significantly overlap at 
stationary phase. We compared the transcriptomes of 35000HP, 35000HP∆dksA and 
35000HP∆relA∆spoT, which is (p)ppGpp°. Four biological replicates were included for 
each strain harvested at the mid-log, transition, and stationary phases of growth (Figure 
33), summing a total of 36 samples.  
The percentage of total reads aligned with the reference genome from all strains, 
growth phase, and replicates range from 82.89- 95.87% (Table 7). We calculated the fold 
change in the expression of genes in 35000HP∆dksA or 35000HPΔrelAΔspoT compared 
to 35000HP. As described previously, we used a false-discovery rate (FDR) of ≤ 0.1 and 
a 2-fold change as criteria for differential transcript expression (166). A positive fold 
change indicates that expression of the gene is higher in the mutant strain while a 
negative fold change signifies that the expression is higher in the parent strain. All 
differentially expressed genes identified in this study are listed in Appendix III.  
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The H. ducreyi genome is comprised of 1758 genes. Comparison of the 
transcriptomes of the (p)ppGpp° mutant to the parent in mid-log, transition, and 
stationary phase yielded 149, 107 and 494 differentially expressed genes, respectively; 
approximately equal numbers of genes were up- and downregulated (Figure 34A). 
Comparison of the transcriptomes of the dksA mutant to the parent in mid-log, transition, 
and stationary phase yielded 58, 184, and 304 differentially expressed genes, 
respectively; the majority of genes were upregulated (Figure 34B).   
Figure 33. Growth kinetics of 35000HP, 35000HPΔrelA∆spoT, and 35000HPΔdksA used for 
RNA-seq. Growth kinetics determined by measuring the CFU at different time points 
following inoculation from overnight cultures. 1, 2, and 3 indicate the time points at which 
bacteria were harvested for transcriptome analysis in the mid-log, transition, and stationary 
growth phases, respectively. 
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Table 7.  Summary of the RNA-seq read statistics 
Bacterial 
Strain 
Growth 
Phase 
Biological 
Replicate 
Total 
Reads 
Aligned 
Reads 
% 
Aligned 
Reads 
% 
Unaligned 
Reads 
35000HP 
Mid-Log 
R1 10,301,365 9,429,934 91.54% 8.46% 
R2 8,402,713 7,676,013 91.35% 8.65% 
R3 10,090,817 9,247,646 91.64% 8.36% 
R4 10,093,183 8,918,683 88.36% 11.64% 
Transition 
R1 17,841,534 14,788,825 82.89% 17.11% 
R2 12,594,439 11,279,753 89.56% 10.44% 
R3 14,468,362 13,087,351 90.45% 9.55% 
R4 12,585,911 11,724,490 93.16% 6.84% 
Stationary 
R1 12,250,624 10,667,706 87.08% 12.92% 
R2 13,022,098 11,743,715 90.18% 9.82% 
R3 11,638,354 10,314,179 88.62% 11.38% 
R4 11,745,737 10,479,877 89.22% 10.78% 
35000HP 
ΔrelAΔspoT 
Mid-Log 
R1 10,222,017 9,800,254 95.87% 4.13% 
R2 9,464,896 8,611,107 90.98% 9.02% 
R3 10,980,962 9,854,192 89.74% 10.26% 
R4 10,483,047 9,585,534 91.44% 8.56% 
Transition 
R1 15,068,994 13,809,711 91.64% 8.36% 
R2 10,800,119 9,994,775 92.54% 7.46% 
R3 12,098,519 10,852,532 89.70% 10.30% 
R4 10,443,013 9,406,044 90.07% 9.93% 
Stationary 
R1 15,008,374 13,617,319 90.73% 9.27% 
R2 10,355,069 9,240,150 89.23% 10.77% 
R3 11,335,796 10,479,164 92.44% 7.56% 
R4 8,205,523 7,542,286 91.92% 8.08% 
35000HP 
ΔdksA 
Mid-Log 
R1 13,075,344 11,631,470 88.96% 11.04% 
R2 11,369,827 10,089,573 88.74% 11.26% 
R3 15,429,356 14,230,161 92.23% 7.77% 
R4 15,350,792 13,965,504 90.98% 9.02% 
Transition 
R1 13,698,233 12,967,727 94.67% 5.33% 
R2 12,114,949 11,048,993 91.20% 8.80% 
R3 10,500,995 9,431,736 89.82% 10.18% 
R4 11,307,711 10,317,164 91.24% 8.76% 
Stationary 
R1 13,934,290 12,469,947 89.49% 10.51% 
R2 13,181,478 12,347,374 93.67% 6.33% 
R3 12,793,798 11,909,717 93.09% 6.91% 
R4 13,875,693 12,545,996 90.42% 9.58% 
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Comparison of the genes differently regulated by loss of DksA to those 
differentially regulated by loss of (p)ppGpp in cells harvested from mid-log, transition, 
and stationary phase yielded 11, 11, and 222 overlapping genes, respectively (Figure 35).  
Figure 34. Venn diagram showing the number of genes differentially regulated by (p)ppGpp 
or DksA deficiency at different phases of growth. (A) 35000HPΔrelAΔspoT compared to 
35000HP; and (B) 35000HPΔdksA compared to 35000HP. The total number of genes or 
operons differentially regulated in different phases of growth is indicated in bold outside the 
Venn diagram. Up () and Down () regulated genes; contra- regulated () in different 
growth phases.  
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To identify the overlap of the genes that were differentially regulated by the loss 
of (p)ppGpp or DksA, we plotted the log10-transformed fold changes in 
35000HPΔrelAΔspoT/35000HP against 35000HPΔdksA/35000HP. At mid-log and 
transition phase, (p)ppGpp and dksA deficiency primarily altered unique sets of genes 
while at stationary phase the differentially expressed genes significantly overlapped and 
were coordinately regulated (Chi-Square = 367.1903; P < 0.001) (Figure 35; Figure 36).  
These data showed that, in stationary phase, (p)ppGpp and DksA deficiency primarily 
alters expression of similar targets. As (p)ppGpp and DksA primarily respond to nutrient 
stress, we focused the remainder of our analysis on the stationary phase transcriptomes.  
Figure 35.  Venn diagram showing the number of differentially regulated genes that overlap 
between (p)ppGpp and DksA deficiency at stationary phase. 35000HPΔrelAΔspoT compared 
to 35000HP versus 35000HPΔdksA compared to 35000HP. The total number of genes or 
operons differentially regulated in different phases of growth is indicated in bold outside the 
Venn diagram. Up () and Down () regulated genes; contra- regulated () in different 
growth phases.  
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Figure 36. Scatter plots showing fold changes in the expression of genes differentially 
expressed in 35000HPΔrelAΔspoT and 35000HPΔdksA compared to 35000HP. The scatter 
plots were generated by plotting the log10-transformed fold changes in 35000HPΔrelAΔspoT 
versus 35000HP against 35000HPΔdksA versus 35000HP at different growth phases. Each 
triangle in the graph indicates a single gene. 
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We validated selected differentially regulated genes using qRT-PCR. We focused 
on the (p)ppGpp° mutant transcriptome as it had the largest number of differentially 
expressed genes. The genes were grouped into 3 categories based on their expression 
levels (low, medium, and high), grouped into up- and downregulated targets, and further 
sub-grouped based on their fold change ranges (2.0-fold to 5.0-fold, 5.1-fold to 10.0-fold, 
and 10.1-fold to 50.0-fold). Representative genes were selected from each category; a 
total of 15 genes were selected for qRT-PCR validation using primer pairs P59-P94 
(Table 2). qRT-PCR analysis confirmed the differential expression of 14/15 genes 
identified by RNA-Seq (Figure 37A). However, hfq expression was 11.67 upregulated by 
RNA-seq but unchanged (0.97) by qRT-PCR (Figure 37B); the reason for this 
discrepancy is unclear. In general, the fold changes derived from RNA-Seq were in good 
agreement with those measured by qRT-PCR (R2 = 0.902).  
There were 3 contra-regulated genes, HD0097, HD0098, and HD0931, identified 
between the DksA and (p)ppGpp deficient sets of differentially regulated genes at mid-
log phase (Figure 35). No other growth phase showed any contra-regulation of genes. To 
confirm that our RNA-seq method could reliably identify contra-regulated genes, we 
performed qRT-PCR using primers P95-P98 and P31/P32. We compared fold change of 
HD0098 in the (p)ppGpp° and dksA mutants. For comparison we also calculated the fold 
changes of a gene not identified as differentially expressed by (p)ppGpp or DksA 
deficiency, menB, and a gene identified to be downregulated by both regulators, ompP2A. 
qRT-PCR validated the contra-regulation of HD0098 (Figure 38).
 
 
96 
Fi
gu
re
 3
7.
 q
R
T-
PC
R
 v
al
id
at
io
n 
of
 th
e 
R
N
A
-S
eq
 d
at
a.
 (
A
) 
F
ol
d 
ch
an
ge
 i
n 
th
e 
ex
pr
es
si
on
 o
f 
ta
rg
et
 g
en
es
 i
n 
35
00
0H
P
Δ
re
lA
Δ
sp
oT
 re
la
tiv
e 
to
 
35
00
0H
P 
in
 s
ta
tio
na
ry
 p
ha
se
. T
he
 c
rit
er
ia
 u
se
d 
fo
r s
el
ec
tin
g 
th
e 
ta
rg
et
s 
fo
r q
R
T-
PC
R
 v
al
id
at
io
n 
ar
e 
ou
tli
ne
d 
in
 th
e 
fig
ur
e.
 T
he
 e
xp
re
ss
io
n 
le
ve
ls
 o
f 
ta
rg
et
 g
en
es
 w
er
e 
no
rm
al
iz
ed
 t
o 
th
at
 o
f 
dn
aE
. 
Th
e 
da
ta
 r
ep
re
se
nt
 t
he
 m
ea
ns
 ±
 S
D
 f
ro
m
 f
ou
r 
in
de
pe
nd
en
t 
ex
pe
rim
en
ts
. 
(B
) 
C
or
re
la
tio
n 
be
tw
ee
n 
th
e 
fo
ld
 c
ha
ng
es
 d
er
iv
ed
 fr
om
 q
R
T-
PC
R
 a
nd
 R
N
A
-S
eq
. 
 
 
97
 
 
Functional classification of genes altered by deficiency of (p)ppGpp° or dksA. 
Using annotations and pathway information from the sequenced 35000HP genome 
(Munson, unpublished) and KEGG, the identified differentially expressed genes were 
classified into multiple functional categories including energy metabolism, biosynthesis, 
transcription, translation, cell membrane and binding (Table 9). In both mutants, pathway 
enrichment analysis with annotations from both Biocyc and DAVID bioinformatics 
resources showed that genes encoding proteins involved in pilus formation, ion transport, 
oxidative reduction/phosphorylation, carbohydrate transport, and cytochrome complex 
assembly were enriched (data not shown). The (p)ppGpp° mutant also showed 
enrichment in genes encoding proteins involved in regulation of transcription and 
translation.  
Figure 38. Relative expression levels of selected H. ducreyi genes in 35000HPΔrelAΔspoT 
and 35000HPΔdksA. The mid-log phase expression levels of menB (unchanged), ompP2A 
(downregulated), and HD0098 (contraregulated) were normalized to that of dnaE. The data 
represent the means ± SD of the results of four independent experiments. 
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Table 8. Functional classification of genes  differentially regulated by (p)ppGpp or DksA 
in stationary phase  H. ducreyi 
 
35000HPΔrelAΔspoT 
/ 35000HPa 
 
35000HPΔdksA 
/ 35000HPb 
Parameter Stationary  Stationary 
% Downregulated Genes 52  62 
% Upregulated Genes 48  38 
 
   
   Regulation  Regulation 
Functional Categoriesc Up Down  Up Down 
Amino acid biosynthesis 2 4  5 1 
Amino acid Transport and metabolism 6 6  5 2 
Amino Sugar and nucleotide metabolism 4 12  2 7 
Cellular carbohydrate biosynthetic process 7 5  3 1 
Carbohydrate metabolism 1 2  3 0 
Cell division 2 5  1 2 
Cell membrane 11 15  9 7 
Cellular homeostasis 4 2  2 1 
Cellular response to stress 0 2  3 0 
DNA binding 3 1  4 2 
DNA metabolic process 8 4  8 1 
Fatty acid biosynthesis and metabolism 7 3  4 2 
Intracellular trafficking and secretion 1 11  1 5 
Ion transport 3 7  2 4 
Iron sulfur cluster binding 2 6  0 3 
Lipid biosynthesis and metabolism 3 4  5 2 
Metal ion binding 10 8  7 5 
Nucleotide binding 8 19  4 11 
Protein fate 7 9  5 5 
RNA binding 4 0  1 0 
RNA processing 9 8  5 3 
Transcription 10 9  2 3 
Translation 15 27  12 6 
Transport of proteins and carbohydrates 7 11  2 6 
Uncharacterized conserved protein 6 10  7 1 
Hypothetical proteins 75 89  30 92 
aGenes differentially expressed in 35000HPΔrelAΔspoT versus 35000HP at stationary phase. 
bGenes differentially expressed in 35000HPΔdksA versus 35000HP at stationary phase. 
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(p)ppGpp° and dksA deficiency leads to dysregulation of virulence 
determinants required for human infection. Since both the dksA and (p)ppGpp° 
mutants were partially attenuated in humans, we determined the effect their deficiency on 
the expression of genes required for human infection. (p)ppGpp deficiency in 35000HP 
resulted in decreased expression of genes in the flp-tad operon, the lspB-lspA2 operon, 
lspA1, hgbA, and csrA, which are all required for pustule formation in humans (Table 9) 
(47, 70, 94). Loss of (p)ppGpp increased the expression of fgbA, which is required for 
virulence (47). These data are consistent with the partial attenuation and some 
phenotypes of the (p)ppGpp° mutant reported previously (164). Deletion of (p)ppGpp 
downregulated expression of cdtC and upregulated expression of OmpP2B, sodC, momp, 
lst, ftpA, neuA, pea, and cpxR, all of which are dispensable for human infection (Table 9). 
The upregulation of expression of ompP2B is consistent with our previous findings that 
deletion of relA spoT resulted in increased expression of the OmpP2B protein in purified 
outer membranes (164).  
DksA deficiency resulted in decreased expression of flp3, hgbA, and lspB, which 
would favor decreased virulence (Table 9, Appendix III) (47). The dksA mutant also had 
increased expression of hfq, dltA, and spoT, which would favor increased virulence (70, 
93, 164). Additionally, deletion of DksA altered expression of genes not required for 
virulence. Genes encoding membrane proteins ompP2B, momp, and ompP4, as well as 
cdtC, ftpA, cpxR and a phosphoethanoloamine transferase are all differentially expression 
in the deletion mutant. These results suggest that the partial attenuation of the dksA 
mutant might also be due to conflicting phenotypes.  
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Table 9. Expression of genes tested for virulence in humans altered by deficiency of  (p)ppGpp or DksA 
  35000HP/ 
35000HPΔrelAΔspoTbc 
35000HP/ 
35000HPΔdksAbd  Gene(s)a Function 
Fully attenuated    flp1-flp2-flp3 Adherence and microcolony 
formation -8.91 -2.33 
dsrA Major role in serum resistance −e − 
lspA1, lspA2 Escape from phagocytosis -5.07 − 
ncaA Collagen binding − − 
tadA Adherence and microcolony 
 
-6.86 − 
hgbA Heme and/or iron uptake -2.54 -2.37 
pal Outer membrane stability − − 
hfq RNA binding chaperone 11.67 2.64 
sapB-sapC Resistance to antimicrobial peptides − − 
cpxA Two component sensor kinase − − 
    Partially 
    dltA Partial role in serum resistance − 4.98 
wecA Initiates synthesis of putative 
glycoconjugate 
− − 
luxS Quorum Sensing − − 
fgbA Fibrinogen binding 2.04 − 
sapA Resistance to antimicrobial peptides − − 
csrA Posttranscriptional regulation -2.34 − 
dksA DnaK repressor; (p)ppGpp co-factor − NA 
relA,spoT (p)ppGpp synthetase and hydrolase; 
stringent response NA 2.09 
    Virulent    hhdBf Lysis of fibroblasts − − 
ompP2A, ompP2B Encode classical trimeric porins 10.28 3.93 
sodC Detoxifies ROSg 2.40 − 
momp OmpA homolog; minor role in 
fibronectin binding 2.81 2.43 
losB Extends LOSh beyond KDOi-
triheptose-glucose 
− − 
lst Adds sialic acid to LOS 2.83 − 
cdtCf Toxic for T cells, epithelial cells, 
and fibroblasts -2.93 -2.47 
ftpA Pilus 7.79 3.03 
tdX/tdhA Heme uptake − − 
glu Adds glucose to KDO-triheptose 
  
− − 
ompP4 Outer membrane lipoprotein − 2.32 
cpxR Two Component Response 
 
7.19 5.89 
neuA Enables sialic acid addition to LOS 2.74 − 
pea 
 
Phosphoethanolamine transferases 2.98 2.04 
aStrains with mutated genes that have been tested in human volunteers and classified as attenuated, partially 
attenuated, or virulent. 
bFold change of first gene is shown for multi-gene mutants   cFold change on 35000HPΔrelAΔspoT relative to 35000HP in 
    dFold change on 35000HPΔdksA relative to 35000HP in stationary 
   e−, no change in expression.   fhhdB cdtC double mutant is also virulent in humans.   gROS, reactive oxygen species. 
  hLOS, lipooligosaccharide. 
  iKDO, 2-keto-3-deoyoctulosonic acid. 
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The set of transcripts altered by (p)ppGpp deficiency significantly overlaps 
with the sets of transcripts controlled by Hfq and CpxRA. Hfq is a major regulator 
of H. ducreyi stationary phase gene expression and contributes to the positive regulation 
of virulence determinants such as LspB, DsrA, and Flp1 (93). Given that both mutants 
upregulated hfq (Table 9) and given the discrepancy in the hfq expression levels 
determined by different methods for the (p)ppGpp° mutant, we determined if the 
transcriptomes of the (p)ppGpp° and DksA mutants significantly overlapped with that of 
the hfq mutant (93). The transcriptomes of the (p)ppGpp° and the hfq mutants were 
negatively correlated and overlapped significantly (Chi-Square = 38.172; P < 0.001), 
while that of the dksA mutant did not. Thus, it is likely that (p)ppGpp deficiency results in 
upregulation of hfq transcription. 
(p)ppGpp and DksA deficiency resulted in 7.19- and 5.89-fold upregulation of 
cpxR, respectively (Table 9). We therefore compared the effects of dksA and (p)ppGpp 
deficiencies on transcription to those produced by activation of CpxRA, defined as the 
transcription effects of a CpxR activating mutant compared to a cpxR deficient mutant in 
stationary phase (166). The differentially expressed genes in dksA mutant did not overlap 
with those of CpxRA. The effects of (p)ppGpp deficiency positively correlated and 
significantly overlapped with effects of activation of CpxRA (Chi-Square = 17.070; P < 
0.001). Since activation of the CpxRA system is associated with loss of virulence, these 
results were consistent with the partial attenuation of the (p)ppGpp° mutant (164).  
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Differential Expression of H. ducreyi putative small RNAs. In E. coli and other 
bacteria, Hfq is crucial for function of small RNAs (sRNAs) (167). sRNAs are non-
protein coding RNAs involved in cell regulatory functions. sRNAs integrate 
environmental stress signals and regulate a plethora of stress responses. Trans-encoded 
regulatory RNAs usually require Hfq as a cofactor to facilitate the interaction between 
sRNAs and their target mRNAs (168, 169). RelA was shown to increase Hfq binding to 
low affinity small RNA targets in E. coli (122). In Salmonella enterica serovar 
Typhimurium, (p)ppGpp is required for expression of 100 known and putative sRNAs 
(170). In Rhizobium etli, activation of the stringent response was implicated in the 
expression of 33 sRNAs (171). We previously identified ten putative H. ducreyi small 
RNAs potentially regulated by Hfq ((93); unpublished). Given the significant overlap 
between the (p)ppGpp regulated genes and Hfq targets, we further analyzed to determine 
if loss of (p)ppGpp or DksA affected expression of these small RNAs.  
At stationary phase, we found that (p)ppGpp deficiency altered expression of 9 of 
the 10 putative small RNAs while DksA deficiency altered expression of 2 of the small 
RNAs (Table 10). These results correlate with the regulon overlap data. The significant 
overlap of the (p)ppGpp regulon with the Hfq regulon as well as the highly upregulated 
levels of hfq in the 35000HPΔrelAΔspoT mutant hint at an interplay of Hfq and (p)ppGpp 
in H. ducreyi. 
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The (p)ppGpp and DksA mutants are defective in adherence to human 
fibroblasts by different mechanisms. The flp-tad operon is composed of a Tad secretion 
system that secretes the fimbria-like proteins Flp1-3, which mediate the adherence of the 
bacterium to HFF cells and are associated with virulence (69). The flp-tad operon was 
downregulated approximately 12-fold in the (p)ppGpp° mutant; only flp3 was 
downregulated 2-fold in the dksA mutant (Table 9; Appendix III). We compared the 
adherence of 35000HP, 35000HPΔdksA, 35000HPΔrelAΔspoT and 35000HPΔflp1-3 
collected at stationary phase to HFF cells. The Δflp1-3 mutant served as a negative 
control for the assay. As expected, both the (p)ppGpp° (66.7 ± 9.5 %) and Δflp1-3 mutant 
(4.6 ± 1.6 %) mutant exhibited reduced attachment compared to the parent (115.8 ± 21.5 
%) (P= 0.0002 and P= < 0.0001, respectively) (Figure 39A). Surprisingly, the dksA 
mutant attached to HFF cells at significantly lower levels (15.9 ± 5.2 %) than the parent P 
= <0.0001) and the ΔrelAΔspoT mutant (P= .019 and at levels that were not significantly 
different than the Δflp1-3 mutant (Figure 39A). Thus, the dksA mutant was more impaired 
than the (p)ppGpp° mutant in attachment to HFF cells. 
The decreased attachment of the (p)ppGpp° mutant likely resulted from decreased 
expression of the Flp proteins. We probed whole cell lysates of the  (p)ppGpp° and dksA 
mutants with a Flp1/2 antisera by Western blot. The tadA and dksA mutants and the 
Δflp1-3 mutant were used as controls for the assay. As expected, the tadA mutant 
expressed the Flp proteins in whole cell lysates while the Δflp1-3 mutant did not (Figure 
39B). Unlike the dksA mutant, compared to the wild type, the (p)ppGpp° mutant 
expressed reduced levels of the Flp proteins (Figure 39B). Thus, the adherence defect in 
the (p)ppGpp° mutant could be attributed to decreased expression of the Flp proteins.  As 
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is shown in Figure 32B, the dksA mutant expressed wild type levels of the Flp proteins in 
both whole cell lysates and outer membranes; the adherence defect of the dksA mutant 
could not be attributed to decreased expression or altered localization of the Flp proteins. 
These data suggest that the adherence defect of the mutants resulted from different 
mechanisms.  
 
 
Figure 39. Adherence of the dksA  and relA spoT  mutants to HFF cells and Flp protein 
expression. (A) Percent adherence of 35000HP, 35000HPΔdksA, 
35000HPΔrelAΔspoT and 35000HPΔflp1-3 to HFF cells calculated as follows: 
(geometric mean CFU of HFF-adherent bacteria/geometric mean CFU of initial 
bacteria added per well) × 100. The data represent the means ± SD from 5 independent 
experiments. *, P ≤ 0.05.  (B) Western blot analysis of whole cell lysates analyzed by 
SDS-PAGE. Samples were probed with Flp1/2 antibody. The anti-PAL MAb 3B9 was 
used to verify equivalent loading. Data are representative of 4 independent 
experiments. 
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Here, we defined genes whose expression is altered by (p)ppGpp and DksA 
deficiency in H. ducreyi. In summary, we provided evidence that in H. ducreyi, (p)ppGpp 
and DksA primarily coordinate regulation of gene expression in stationary phase. We 
also demonstrated that (p)ppGpp and DksA control some unique targets highlighting their 
independent functions in bacterial gene regulation.  
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Chapter VI: 
 
Discussion 
 
Here we showed that H. ducreyi ΔrelAΔspoT and ΔdksA mutant were partially 
attenuated for virulence in human volunteers, indicating that the stringent response plays 
an important role in H. ducreyi pathogenesis. A summary of phenotypes regulated by 
(p)ppGpp or DksA are depicted in Figure 40. We provided evidence that (p)ppGpp and 
DksA likely contribute to regulation of gene expression in stationary phase. Taken 
together, our study suggests an important role for (p)ppGpp and DksA in controlling 
H. ducreyi stationary phase and virulence gene expression. 
For those bacterial species that contain stringent response homologs, insight into 
the in vivo significance of the stringent response has been pursued by conducting studies 
in small mammals and extrapolating findings to human infection. We have the ability to 
determine the in vivo significance of bacterial pathogen in humans. Our study offers the 
unique opportunity to examine the effect of the stringent response in bacterial virulence 
within the human host. To our knowledge, this was the first study that evaluated 
(p)ppGpp and DksA in the context of a human infection. 
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Contribution of (p)ppGpp to H. ducreyi virulence 
We constructed a relA deletion mutant and a relA spoT double mutant in H. 
ducreyi but were unable to recover a spoT deletion mutant. In other organisms, 
expression of a (p)ppGpp synthase in the absence of a hydrolase leads to growth arrest 
and cell death; therefore, for many species, spoT is considered an essential gene (138, 
153). In a radiolabeling-based de novo (p)ppGpp synthesis assay, both the H. ducreyi 
relA and relA spoT mutants were unable to synthesize (p)ppGpp. As there is no defined 
media available for H. ducreyi, one limitation of our study data is that we did not evaluate 
(p)ppGpp synthesis in response to nutrient stress. Nutrient limitation is usually used to 
enhance the synthetase activity of these enzymes. Given that deletion of relA alone was 
sufficient to abolish the ability of H. ducreyi to synthesize (p)ppGpp and that we were not 
able to construct a spoT mutant in the presence of relA, these data suggest that RelA is 
likely the primary (p)ppGpp synthetase and that SpoT is likely the primary (p)ppGpp 
hydrolase in H. ducreyi. 
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Human volunteers formed pustules at a significantly lower rate in response to the 
relA spoT double mutant compared to the parent strain; therefore, the double mutant met 
the criteria for partial attenuation in the model (47). Since OmpP2B is not required for 
pustule formation in humans (172), the increased expression of OmpP2B by the mutant 
likely had no effect on its virulence. The increased sensitivity to oxidative stress and 
growth phase dependent reduction in the expression of DsrA favor attenuation of the 
mutant. However, the decreased uptake by macrophages and the increased longevity of 
the mutant in stationary phase favor virulence. DksA overexpression may phenotypically 
compensate for the loss of (p)ppGpp in a (p)ppGpp0 mutant in E. coli (134). Thus, 
increased dksA expression may have partially compensated for the loss of (p)ppGpp in 
the mutant and contributed to the partial attenuation of the mutant in vivo. 
 
 
Figure 40. Model of phenotypes altered by (p)ppGpp or DksA deficiency. Top: Diagram of 
the stringent response system. (p)ppGpp is synthesized by two parallel pathways. After 
synthesis, (p)ppGpp then interacts with DksA and RNAP to drive transcription in favor or 
survival.  Bottom: Phenotypes associated with either (p)ppGpp deficiency (left) or DksA 
deficiency (right). Adapted from Figure 1. 
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Contribution of DksA to virulence 
In E. coli, DksA is a transcription factor that acts by binding directly to the RNAP 
and amplifies the effects of (p)ppGpp to enhance the stringent response. In addition to its 
critical role in the stringent response, DksA can interact with RNAP and regulate gene 
transcription independently of (p)ppGpp expression. The rate of pustule formation in 
response to the dksA mutant was significantly lower than to he isogenic parent strain in 
human volunteers; the dksA mutant met the criteria for partial attenuation in the model 
(47). Similarly, a dksA deletion mutant of Salmonella enterica serovar Typhimurium is 
attenuated in both chick and murine models of infection (133, 173, 174).  
The ability of H. ducreyi to attach to human foreskin fibroblasts has also been 
correlated with virulence, and the dksA mutant showed decreased attachment to HFF cells 
compared to the parent. Similarly, studies in pathogenic and nonpathogenic bacteria show 
that dksA mutants tend to have decreased attachment to eukaryotic cells as well as 
decreased expression of genes involved in the regulation of attachment (134, 163, 165). 
We found no evidence for decreased expression or altered localization of the Flp proteins 
in the dksA mutant. Taken together, these data suggest that DksA affects adherence to 
HFF cells through another mechanism, such as regulating one or more yet-to-be defined 
co-factors that are required for Flp-mediated adherence.  
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Regulation of H. ducreyi genes by stringent response mediators 
In cells harvested from stationary phase, loss of (p)ppGpp and dksA led to 
differential expression of 28% and 17% of the H. ducreyi open reading frames, 
respectively. We found that many of the differentially regulated genes identified in our 
study have been previously associated with the stringent response (158, 163). (p)ppGpp 
and DksA deficiency in H. ducreyi resulted in altered expression of genes involved in 
transcription, translation, biosynthesis of macromolecules, and energy metabolism. 
Functional pathways enriched in the differentially expressed genes are depicted in Figure 
41. This is consistent with findings in E. coli that the (p)ppGpp/DksA system regulates 
genes necessary for adaptation to nutritional stress (134, 158, 163). Comparison of the 
sets of genes differentially expressed by the (p)ppGpp° and dksA mutants in stationary 
phase showed a significant overlap. This data indicated that, in stationary phase, the 
genes affected by lack of (p)ppGpp and DksA in H. ducreyi are highly co-regulated. As 
the majority of genes altered by (p)ppGpp and DksA deficiency were identified in 
stationary phase, this data also indicates that these two regulators may play roles in 
stationary phase gene regulation.  
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Regulation of stringent response is one of the well-established roles of (p)ppGpp 
and DksA. In response to nutrient stress, (p)ppGpp controls stringent response by a trade-
off wherein the RNAP is redistributed from replicating activities to maintenance and 
repair (175, 176). An alternative theory argues that (p)ppGpp and DksA induce 
programmed cell death upon growth arrest by regulating a chromosomally located toxin-
antitoxin locus (176, 177). Despite entering stationary phase earlier, both the (p)ppGpp 
and DksA mutants survived longer than the wild-type strain in stationary phase. To our 
knowledge, this is the first study reporting the increased longevity of a bacterial pathogen 
upon deletion of (p)ppGpp and DksA. These data suggest that (p)ppGpp and DksA 
deficiency could fail to trigger programmed cell death during stationary phase in H. 
ducreyi. 
Figure 41. Model of functional pathways altered by (p)ppGpp or DksA deficiency. Enriched 
Pathways associated with either (p)ppGpp deficiency (left) or DksA deficiency (right). 
Adapted from Figure 1. 
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Summary 
Both the dksA mutant and (p)ppGpp° mutant were partially attenuated for pustule 
formation in human volunteers. While inoculation with the (p)ppGpp° mutant resulted in 
papules whose sizes were not significantly different than the parent, the dksA mutant 
caused significantly smaller papules than the parent. Although we have not compared the 
two mutants directly in human volunteers, the data suggest that the DksA and (p)ppGpp 
might have different effects on virulence. The dksA mutant was taken up more readily 
than the parent by macrophages while the (p)ppGpp° mutant was phagocytized less 
readily than the parent. Both the dksA mutant and the (p)ppGpp° mutant exhibited 
increased sensitivity to oxidative stress. This increased sensitivity could be linked to 
decreased survival within macrophages seen in both the dksA and (p)ppGpp° mutants. 
Both the dksA mutant and the (p)ppGpp° mutant exhibited decreased attachment to HFF 
cells; however, the decreased attachment likely resulted from different mechanisms. 
Taken together, the data suggest that DksA and (p)ppGpp have both distinct and 
overlapping functions. 
There is a strong possibility that (p)ppGpp and DksA mutually compensate for 
one another in vivo. As depicted in Figure 40, absence of (p)ppGpp does not preclude 
interaction of DksA with RNAP; the reverse is also true. Additionally, (p)ppGpp and 
DksA deficiency result in alteration of similar genes and functional pathways (Figure 41). 
It is therefore difficult to ascertain the primary cause of a particular phenotype: deletion 
of the mediator or compensation by its partner.  
One limitation of our study is that we only examined the mutants for a limited 
number of phenotypes that are usually associated with the virulence of H. ducreyi in 
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human volunteers. Given the pleiotropic effects of (p)ppGpp and DksA deficiencies on 
gene transcription, it is likely that other factors played a role in the attenuation of the 
mutants. Nevertheless, our findings suggest important role for (p)ppGpp and DksA in H. 
ducreyi virulence in humans. Our findings also highlight the underappreciated roles of 
(p)ppGpp and DksA in regulating phenotypes associated with stationary phase.  
Another limitation of our study is that we did not define the (p)ppGpp 
transcriptome in response to nutrient stress. Recent studies, however, have demonstrated 
the importance of basal levels of (p)ppGpp in regulation of genes and metabolic 
processes in absence of a stringent response (178-180). Therefore, despite lack of 
induction of a stringent response, our study is highly relevant to defining the effect of 
(p)ppGpp deficiency on virulence of H. ducreyi. As DksA functions independently of 
(p)ppGpp and is not known to respond to any defined stresses, defining the DksA 
deficient transcriptome is a valid method of identifying DksA-dependent differentially 
regulated genes.  
Based on our in vitro and transcriptome data presented in this thesis, we have 
shown a potential role for the stringent response in H ducreyi. Using some extrapolations 
from both H. ducreyi and E. coli literature, we propose a stringent response model in H. 
ducreyi in Figure 42. In H. ducreyi, stringent response activation will lead to upregulation 
of genes involved in amino acid biosynthesis, proteolysis and nutrient transport. 
Upregulation of these particular functional categories will increase amino acid 
availability and external nutrient acquisition. Simultaneously, genes that code ribosomal 
proteins and elongation factors are downregulated along with genes involved in fatty 
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acid, lipid and protein synthesis. The ultimate goal is to inhibit cell division until 
nutrients become available. 
In addition to genes directly involved in nutrient synthesis, the stringent response 
upregulates expression of stasis survival genes and universal stress proteins although it 
appears to downregulate the alternative sigma factor, rpoE. rpoE upregulates genes 
involved in envelope maintenance and repair as well as rpoH, which upregulates heat 
shock proteins and chaperones. By upregulating universal stress proteins, the stringent 
response is utilizing multiple mechanisms to address a potentially lethal condition. In H. 
ducreyi, rpoE upregulates CpxRA and Hfq. As stated previously, Hfq and CpxRA 
regulate virulence determinants such as LspA1 and DsrA; Hfq upregulates their 
expression, while CpxRA downregulates these targets. cpxR and hfq  are upregulated in 
both the (p)ppGpp and DksA deficient mutants suggesting that they may be inhibited by 
the stringent response.  
sRNAs can be used to regulate metabolic processes in bacteria. In S. 
Typhimurium, a large percentage of the (p)ppGpp-dependent sRNAs were directly 
involved in nutrient acquisition or synthesis. The stringent response in H. ducreyi may or 
may not directly regulate expression of putative sRNAs. It is possible that the altered 
regulation of sRNAs in the deficient mutants is indirect and mediated by Hfq.  
Nutrient stress likely leads to translation blocks that may result in the synthesis of 
truncated or misfolded proteins. For this reason, the stringent response may be involved 
in an integrated stress response network in H. ducreyi that involves multiple systems. The 
final outcome of this interplay, as depicted in Figure 42, is unclear. It will be interesting 
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to continue determining how H. ducreyi utilizes this complicated network of stress 
components for virulence.  
In summary, we show that DksA and (p)ppGpp likely serve as major contributors 
of virulence and stationary phase gene regulation in H. ducreyi. We also show that, 
despite similar gene expression patterns, the dksA and (p)ppGpp° mutants are 
phenotypically distinct. Future studies will focus on identifying (p)ppGpp and/or DksA-
dependent proteins to better understand the unique intersecting and diverging roles the 
two regulators play in H. ducreyi virulence. 
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Chapter VII: 
 
Future Directions 
 
The data presented in this thesis add a critical level of detail to the study of 
(p)ppGpp and DksA in direct virulence of a human pathogen, which was previously 
lacking in the field. Prior to this study, researchers had not examined the intricate role the 
stringent response plays in direct regulation of virulence genes required for human 
infection. By detailing the mechanisms by which (p)ppGpp and DksA affect virulence, 
we have added an important element to the bacterial pathogenesis field.  
 
Identification of an in vitro trigger for stringent response in H. ducreyi 
Although there has been a substantial body of work published detailing natural 
induction of the stringent response in other organisms, it is important to determine how 
the stringent response is induced in H. ducreyi. Traditionally, culturing bacteria in 
minimal media lacking one or more key nutrients such as serine induces the stringent 
response. The minimal media allows supplementation with nutrients in case species-
specific auxotrophies are discovered. In the absence of minimal medium, many 
investigators utilize drug treatments to mimic nutrient deprivation.  
To find a natural trigger of H. ducreyi, we will take advantage of chemical 
induction to identify stringent response triggers. Using one of the chemical mimics 
described below, we will first measure de novo synthesis of (p)ppGpp in wild type 
harvested from mid-log phase bacteria. We did not see large amount of de novo (p)ppGpp 
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production in mid-log phase 35000HP. Thus, we will use untreated mid-log phase 
35000HP to establish basal (p)ppGpp production as a comparison to chemically induced 
synthesis. The ΔrelA and ΔrelAΔspoT mutants will also be used in these assays to verify 
chemical induction.  
Amino acid starvation is the primary inducer of the stringent response and induces 
RelA to synthesize (p)ppGpp. Serine hydroxamate is commonly used to mimic amino 
acid starvation by inhibiting charging of seryl-tRNA ribonucleic acid, reducing the 
synthesis of nucleic acids (181). 35000HP should produce (p)ppGpp if serine starvation 
is a stringent response trigger in H. ducreyi. In E. coli, RelA is the only stringent response 
enzyme that recognizes amino acid starvation. If the H. ducreyi RelA functions in a 
similar manner, both the ΔrelA and ΔrelAΔspoT mutants would be incapable of 
producing (p)ppGpp in response to serine hydroxamate.  
In contrast, SpoT responds to a variety of nutrient signals. SpoT synthesis of 
(p)ppGpp is triggered by fatty acid and carbon starvation. Cerulenin mimics fatty acid 
starvation through inhibition of β-keto-acyl-ACP synthase, permanently inhibiting the 
enzyme (182, 183). If H. ducreyi is sensitive to fatty acid limitation, 35000HP will 
synthesize (p)ppGpp after treatment with cerulenin. In E. coli, relA mutants are still 
capable of producing (p)ppGpp because SpoT is fully functional. If H. ducreyi SpoT has 
synthetic capacity and a similar trigger as E. coli, then a H. ducreyi relA mutant would 
synthesize (p)ppGpp in response to cerulenin.  
Lastly, supplemented GC broth is carbon rich. α-methlyglucoside is a competitive 
inhibitor of glucose transport and can mimic carbon starvation in bacteria (184-186); 
treated cells transport significantly less glucose than untreated cells. This chemical would 
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result in less uptake of glucose, which might trigger a stringent response in H. ducreyi. 
As carbon starvation is a known SpoT- dependent synthesis trigger, the relA mutant will 
likely produce (p)ppGpp, (187, 188). However, it would be interesting to determine 
whether a csrA (carbon storage regulator) mutant responds to this method of carbon 
starvation. If CsrA induces accumulation of (p)ppGpp, the csrA mutant, which may not 
sense carbon stress, might not synthesize (p)ppGpp. If (p)ppGpp is not involved in CsrA 
response to carbon limitation, there should be basal levels of (p)ppGpp in the csrA 
mutant. 
Nutrient deprivation is not the only known trigger of the stringent response. 
Induction of the stringent response has been shown to occur during anaerobic growth 
(111, 189). H. ducreyi is a facultative anaerobe. During infection, the abscess in which H. 
ducreyi resides can vary from an oxygen rich to an anaerobic environment. Thus, an 
anaerobic environment may be a more natural environment for H. ducreyi; anaerobic 
growth or an anaerobic shift may be a natural in vivo trigger for the stringent response. 
35000HP may have evolved a dual sensory mechanism to stress; therefore it is possible 
that both RelA and SpoT sense anaerobic conditions. Thus, both the ΔrelA and 
ΔrelAΔspoT mutants should be assayed for de novo (p)ppGpp synthesis during and after 
anaerobic growth. 
Additionally, characterization of the transcriptional response to anaerobic 
conditions may also help elucidate genes that are more directly required for in vivo 
anaerobic growth and potentially identify the stringent response as an anaerobic response 
regulator in H. ducreyi. 
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Site directed mutagenesis of the H. ducreyi SpoT  
As SpoT is the only (p)ppGpp hydrolase in E. coli, it is considered an essential 
gene. Without SpoT, the stringent response cannot be turned off. Given that the stringent 
response halts growth and inhibits synthesis of new macromolecules, a perpetual 
stringent response is toxic to bacteria. For this reason, there are no E. coli spoT deletion 
mutants. Similarly, we were unable to construct a spoT deletion mutant in H. ducreyi 
indicating that in H. ducreyi, SpoT is likely critical for hydrolysis of (p)ppGpp.  
In E. coli, SpoT is capable of synthesizing (p)ppGpp in response to a plethora of 
triggers. E. coli relA mutants, when given the right stimulus, synthesize (p)ppGpp; 
without the correct stimuli, E. coli relA mutants do not accumulate (p)ppGpp. Our relA 
mutant did not synthesize (p)ppGpp in vitro; therefore, we have no evidence that H. 
ducreyi SpoT functions as a (p)ppGpp synthetase. However, it is possible that our relA 
mutants are simply lacking the proper stimulus for SpoT-dependent (p)ppGpp production 
in our system. The (p)ppGpp synthesis detected in our assay is likely RelA-dependent; 
this does not preclude the possibility that the H. ducreyi SpoT has synthetic capability. 
To better elucidate the specific role of SpoT in H. ducreyi, we must first make a 
few assumptions. We will first assume that the H. ducreyi and E. coli SpoT proteins 
function similarly. If this first assumption is true, we will then assume that the H. ducreyi 
SpoT has both synthetase and hydrolase activity. The final assumption is that given the 
appropriate in vitro stimulus, the H. ducreyi SpoT will synthesize (p)ppGpp in our 
labeling assay.  If these assumptions hold true, spoT point mutations in the hydrolase 
domain can be constructed on plasmids and ectopically expressed in the ΔrelAΔspoT 
 
 
122 
background. In these mutant strains, any (p)ppGpp synthesis that is detected is a direct 
result of SpoT synthetic activity.  
Site-directed mutagenesis or overlapping primer extension could be utilized to 
construct the SpoT mutated genes. As illustrated in Figure 1, the active domains of the H. 
ducreyi and E. coli SpoT proteins are highly similar. Thus, we can begin constructing H. 
ducreyi SpoT mutant proteins by targeting amino acids deemed necessary for enzymatic 
activity of the E. coli SpoT protein.  
In E. coli, SpoT a D73N mutation has been shown to prevent hydrolysis of 
(p)ppGpp (190). D73N containing strains have a constitutively active stringent response. 
It is possible that some of our difficulties visualizing (p)ppGpp in stationary phase were a 
result of rapid hydrolysis of (p)ppGpp by SpoT. The SpoT hydrolase mutants will 
accumulate (p)ppGpp, thus leading to their eventual lethality. This mutant could therefore 
be used to detect (p)ppGpp in a low induction condition or in stationary phase where 
there was minimal (p)ppGpp detection. 
In addition to the hydrolase mutant above, we would also construct synthetase 
mutants. SpoT D259N and D293A mutations in E. coli result in bacterial strains that are 
incapable of synthesizing (p)ppGpp (190). These mutations would be useful in a relA+ 
background. Both mutations would be useful for elucidating RelA-specific nutrient 
triggers, particularly if these are indistinguishable from SpoT nutrient triggers by other 
methods. In contrast to the SpoT D73N strain, any (p)ppGpp synthesis that is detected in 
the synthetase mutant strain could only be produced by RelA.  
After identification of a trigger that induces (p)ppGpp in the wild type H. ducreyi, 
the mutated SpoT proteins can be utilized as tools to identify which enzyme, RelA or 
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SpoT, is the primary synthetic partner.. These SpoT mutations will result in 
monofunctional SpoT proteins that are incapable of either synthesizing or hydrolyzing 
(p)ppGpp. As stated previously, all of these amino acids are conserved in H. ducreyi 
SpoT and will likely result in similar phenotypic outcomes 
 
Genes and mutants for further study 
One major phenotype of both mutants is prolonged stationary phase survival. 
Both the relA spoT and dksA mutants had increased expression of survival genes surE 
and surA. These genes are associated with stationary phase survival of E. coli and 
Thermotoga maritima (115, 116, 118). If these genes are responsible for the increased 
stationary phase survival of the (p)ppGpp° and dksA mutants, then deletion of surA/surE 
in the relA spoT and dksA mutants should result in stationary phase survival to similar to 
wild type levels. The construction of isogenic mutants that eliminate one or both genes in 
35000HP would also prove useful in ascertaining the role of the survival-associated genes 
in H. ducreyi virulence.   
Finally, one of the most interesting questions to arise from this research is: what is 
the identity of the novel Flp-independent adhesin? We found no evidence for decreased 
expression or altered localization of the Flp proteins in the dksA mutant. Taken together, 
these data suggest that DksA affects adherence to HFF cells through another mechanism, 
such as regulating one or more yet to be defined co-factors that are required for Flp-
mediated adherence. A UPEC dksA mutant is impaired in its ability to adhere to 
eukaryotic cells, perhaps due to downregulation of Type 1 fimbriae expression (134). 
Other studies in E. coli and EHEC also indicate that dksA mutants tend to have decreased 
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attachment as well as decreased expression of genes involved in the regulation of 
attachment (163, 165). For identification of the putative adhesin, we used the PSORTdb, 
a database of protein subcellular localization predictions for bacteria. We were able to 
narrow the potential co-factor to one gene, HD1123 or pilA (191). 
In Gram-negative bacteria, PilA/PilE is the main constituent of the Type IV pilus. 
Type IV pili are multifunctional structures involved in adhesion to and invasion of host 
cells, formation of microcolonies and biofilms, DNA uptake and twitching motility (192). 
The H. ducreyi genome contains a pilABCD locus as well as homologs of other key 
components of the pilus: pilF, pilM, pilN, pilO, pilT, and pilQ. In E. coli, pilC encodes 
the tip-located adhesin while pilD encodes the prepilin peptidase responsible for cleaving 
prepilins and N-methylating the mature pilins (193). PilB/PilF and PilT are the ATPases 
that power pilus assembly and retraction respectively (193). PilM, PilN, and PilO 
assemble the Type IV pilus (193).  The pilQ-encoded protein provides the channel for 
secretion of the pilus across the outer membrane (193). H. ducreyi lacks pilG, which is 
thought to function as a response regulator that is critical in other species for pilus 
assembly (194).  
The H. ducreyi pilABCD locus is fully intact indicating that the pilin it can be 
formed. However, the H. ducreyi pilM and pilN are defective due to an internal stop 
codon and a frameshift mutation respectively (195). Therefore, only one of the three 
assembly proteins is intact in H. ducreyi. If this is the case, the H. ducreyi pilABCD locus 
may not be able to assemble a Type IV pilus structure, consistent with reports that 
another class of pili, not Type IV pili, are expressed by H. ducreyi (196-198).  
Nevertheless, in the dksA mutant, expression of pilA is downregulated (-4.76 fold) while 
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the (p)ppGpp mutant has no change in pilA expression.  Importantly, pilA has been 
implicated as a key mediator of attachment and biofilm formation in several species 
including Neisseria meningitidis, Burkholderia pseudomallei and Francisella tularensis 
(199-203). We are currently characterizing a pilA mutant for its ability to attach to 
fibroblasts.   
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Appendix I: 
 
Characterization of a 35000HP∆relA∆spoT∆dksA triple deletion mutant 
 
(p)ppGpp and DksA often work in concert to regulate key genes in many bacterial 
species. As we showed in this work, these two mediators have significantly overlapping 
targets in vitro. (p)ppGpp and DksA deficiencies result in pleiotropic effects that can 
overlap between mutants. Given this overlap, it is often difficult to delineate between the 
independent and collective roles that (p)ppGpp or DksA play in in vitro phenotypes and 
virulence. To discern effects due to compensation of one factor for the other, we decided 
to construct a mutant lacking all three genes. 
 Using the plasmid pCH21 discussed in Chapter 4, dksA was deleted in the 
(p)ppGpp° mutant background. All three gene deletions were confirmed by PCR and 
sequencing (Figure 43). Once the triple mutant was confirmed, we next conducted 
preliminary experiments to determine the usefulness of the triple mutant in our study. 
 
 
Figure 43: PCR confirmation of the 35000HP∆relA∆spoT∆dksA triple deletion mutant. Lane 
1, 35000HP and Lane 2, 35000HP∆relA∆spoT∆dksA. Products were of the expected sizes: 
P23/24: relA int, P25/P26: spoT int, P27/P28: dksA int, and P1/P2: dnaE int. 
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 Both the (p)ppGpp° and dksA mutants are sensitive to oxidative stress. However, 
only the (p)ppGpp° mutant exhibited decreased expression of sodC transcripts. 
Downregulation of sodC, a superoxide dismutase, would increase susceptibility to 
oxidative stress; sodC expression confers resistance to pyrogallol in vitro and a ∆sodC 
mutant was more sensitive to 2 mM pyrogallol than 35000HP.  However, the survival 
rate for 35000HP was approximately 10%, indicating that even the wild type strain, 
exhibits low tolerance for this chemical. We therefore decided to perform a dose response 
with the sodC mutant to pinpoint a concentration of pyrogallol that inhibited survival of 
the sodC mutant but not the parent strain. We chose a cutoff of less than 80% survival as 
indicative of pyrogallol sensitivity. By this standard, the ∆sodC mutant showed 
sensitivity at 0.2 mM pyrogallol while the parent showed sensitivity at approximately 0.8 
mM pyrogallol (Figure 44). 
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As both the ∆dksA and ΔrelAΔspoT are sensitive to oxidative stress, we 
hypothesized that the ∆relA∆spoT∆dksA mutant would be more sensitive to pyrogallol 
than both the ∆dksA and ∆relA∆spoT mutants. To this end, we treated 35000HP, 
35000HP∆dksA, 35000HP∆relA∆spoT and 35000HP∆relA∆spoT∆dksA with 0.05, 0.1, 
and 0.2 mM pyrogallol. None of the deletion mutants were sensitive to 0.05mM 
pyrogallol. Further, the ∆dksA and ∆relA∆spoT mutants were only sensitive to 0.2 mM 
pyrogallol (Figure 45). The triple mutant, however, is highly sensitive to 0.1 and 0.2 mM 
pyrogallol (Figure 45). Thus, this mutant was useful in showing synergistic effects of 
(p)ppGpp and DksA deficiency.  
 
Figure 44: Validation of 35000HP∆sodC mutant sensitivity to pyrogallol. 35000HP and 
35000HP∆sodC were incubated with increasing concentrations of Pyrogallol and assayed for 
virulence. Data are from 3 independent assays. No statistics were done for this assay. 
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(p)ppGpp and DksA deficiency resulted in a decreased ability to attach to HFF 
cells. The (p)ppGpp° mutant has reduced expression of the Flp proteins, which mediate 
attachment, while the DksA mutant expresses wild type levels of the Flps. It is possible 
that the increased expression of dksA in the (p)ppGpp° mutant allowed partial expression 
of flp1-3. Without dksA compensation, the triple mutant may express reduced levels of 
Flp proteins; thus, we next determined expression levels of the Flp1/2 proteins in the 
triple mutant. 35000HP∆relA∆spoT∆dksA expresses almost no Flp protein compared to 
the parent strain (Figure 46). The reduced expression of the Flp proteins suggested that 
Figure 45. H. ducreyi survival after treatment with pyrogallol. Percent survival of 35000HP,  
35000HP∆dksA, 35000HP∆relA∆spoT and 35000HP∆relA∆spoT∆dksA  following incubation 
with 0.05, 0.1 or 0.2 mM pyrogallol for 1 hour. All percent survivals were calculated as 
[(geometric mean CFU after treatment/ geometric mean before treatment) x 100]. The data are 
mean ± SD from five independent experiments. *, P ≤ 0.05. 
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the triple mutant might be more impaired than either the ΔrelAΔspoT or ∆dksA mutants 
in an adherence assay; we next performed an adherence assay with the triple mutant. 
 
 
 
As expected, the triple mutant was defective in adherence to HFF cells (Figure 
47). Both the (p)ppGpp° and the dksA mutants exhibit decreased adherence as has been 
shown previously in Figures 31 and 39. The adherence defect seen in the (p)ppGpp° 
mutant is Flp-dependent while the defect in the dksA mutant appears to be Flp-
independent. The triple mutant was as defective in adherence as both the dksA and flp1-3 
mutants.   Thus, deletion of dksA in the (p)ppGpp° mutant significantly reduced 
adherence of H. ducreyi  to HFF cells. Taken together with the dksA  mutant data, this 
confirms that DksA regulates an Flp-independent adhesin.  
 
 
Figure 46. Expression of Flp protein in the 35000HP∆relA∆spoT∆dksA mutant. Western blot 
analysis of whole cell lysates analyzed by SDS-PAGE.. Samples were probed with Flp1/2 
antibody. The anti-PAL MAb 3B9 was used to verify equivalent loading. Data are 
representative of 2 independent experiments. 
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The (p)ppGpp° mutant exhibited reduced expression of DsrA at mid-log and 
stationary phase, yet plate grown organisms did not exhibit increased sensitivity to 
serum-mediated killing. The dksA mutant expressed wild type levels of DsrA at mid-log 
phase and was also not sensitive to serum killing. Surprisingly, when we examined 
expression levels of DsrA at mid-log phase, the triple mutant expressed no DsrA (Figure 
48). The decreased expression of DsrA suggests that the triple deletion mutant would be 
more sensitive to serum-mediated killing than either the (p)ppGpp° and dksA mutants; 
thus, we decided to conduct a serum bactericidal assay with the triple mutant. 
 
Figure 47. Adherence of the 35000HP∆relA∆spoT∆dksA mutant to HFF cells. Percent 
adherence of 35000HP, 35000HPΔdksA, 35000HPΔrelAΔspoT, 35000HPΔrelAΔspoTΔdksA 
and 35000HPΔflp1-3 to HFF cells calculated as follows: (geometric mean CFU of HFF-
adherent bacteria/geometric mean CFU of initial bacteria added per well) × 100. The data 
represent the means ± SD from 5 independent experiments. *, P ≤ 0.05.   
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The triple mutant was significantly more sensitive to serum-mediated killing than 
the wild type (Figure 49). Neither the (p)ppGpp° nor the dksA mutants exhibit sensitivity 
to serum-mediated killing as has been shown previously in Figures 16 and 27. Although 
neither the (p)ppGpp° or dksA  mutants show decreased transcript of dsrA, it is possible 
that the reduced level of DsrA in the triple mutant is due to posttranslational regulation. 
As we did not perform qRT-PCR for dsrA expression on the triple deletion mutant, we 
cannot exclude that reduced expression is due to decreased transcription.  
Figure 48: Expression of DsrA in the 35000HP∆relA∆spoT∆dksA mutant.  Western blot 
analysis of whole cell lysates analyzed by SDS-PAGE. Samples were probed with antibody 
against DsrA. The anti-PAL MAb 3B9 was used to verify equivalent loading. Data is 
representative of 2 independent experiments. 
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The triple mutant will be useful in studies in which it is critical to identify which 
gene is primarily responsible for a particular phenotype. We provide some evidence that 
DksA can compensate for (p)ppGpp deficiency and that (p)ppGpp and DksA regulate 
similar gene targets.  We also provide evidence that DksA and (p)ppGpp deficiencies can 
result in conflicting phenotypes. For example, the (p)ppGpp° mutant is more resistant to 
uptake by macrophages while the dksA mutant is less resistant. Would the (p)ppGpp° 
mutant exhibit even greater resistance to phagocytosis if dksA overexpression were not 
occurring? The triple mutant could provide the perfect control to answer such a question.  
 
Figure 49. Sensitivity of the 35000HP∆relA∆spoT∆dksA mutant to complement-replete 
human serum. Percent survival of 35000HP, 35000HPΔrelAΔspoT, 
35000HPΔrelAΔspoTΔdksA and dsrA mutant strain FX517 in NHS. Survival was calculated 
as [(geometric mean CFU in NHS/geometric mean CFU in heat-inactivated NHS) × 100]. 
Data are means ± SD of five independent experiments. All strains were compared to 
35000HP. *, P ≤ 0.05.   
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The triple mutant may be able to serve as a (p)ppGpp°  mutant with wild type 
dksA levels. As we demonstrated in Figure 30, despite dksA transcripts being expressed 
on a multicopy plasmid with a constitutively active promoter, 35000HP∆dksA (pCH24) 
expresses wild type levels of dksA. Therefore, usage of pCH24 in the triple deletion 
mutant might result in a (p)ppGpp° mutant that expresses dksA transcripts at levels 
equivalent to 35000HP.  If this is true, this strain could be used alongside the null 
(35000HP∆relA∆spoT∆dksA) and overexpressing strain (35000HP∆relA∆spoT)to 
pinpoint functional compensation of (p)ppGpp by DksA. As the triple mutant removes 
both regulators, it may not be directly useful in the identification of dual functional 
compensation.  
 In conclusion, we showed that the triple mutant shows cumulative effects of 
(p)ppGpp and DksA deficiencies. Compensation with specific stringent mediators of 
interest can help reveal compensatory effects in H. ducreyi. In summary, in the triple 
mutant, we have provided a unique tool to further study the stringent response in H. 
ducreyi. 
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Appendix II: 
 
Inducible relA and dksA expression 
 
An alternative approach to understanding the role of (p)ppGpp and DksA play in 
H. ducreyi pathogenesis is to overexpress these genes. To this end, we constructed 
plasmids to induce expression of RelA -and subsequently induce expression of (p)ppGpp- 
and DksA. To complement the relA spoT deletion mutant, the relA and dksA genes were 
expressed in expression vector pT.  
The expression vector pT contains a tetracycline-inducible promoter on the pLS88 
backbone (204).  Induction of the gene occurs by addition of 200 ng/μl of 
anhydrotetracycline. Preliminary analysis showed that 35000HP transformed with a pT 
vector containing rpoE had severe growth defects in broth (89). This raised the possibility 
that genes were being expressed in the absence of induction. To reduce the leakiness of 
the tet promoter, a 1.2-kb spectinomycin cassette from pSPECR was digested with 
BamHI and ligated into pT in an orientation opposite to the promoter. The orientation of 
the spectinomycin cassette acts to dampen the leakiness of the tet promoter. This 
construct was designated pDG10 (89). 
To construct these expression vectors, the coding region of the gene was 
amplified. The amplicons contain an NdeI site at the 5′ end and a BamHI site at the 3′ end 
to ensure that the target genes are introduced into the pT backbone in the correct 
orientation. The relA open reading frame along with 21 bp of the upstream and 22 bp of 
the downstream regions were amplified using primers 11-P1/11-P2 (Table 11). The final 
plasmid was named pCH5. The dksA open reading frame along with 21 bp of the 
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upstream and 22 bp of the downstream regions were amplified using primers 11-P3/11-
P4. The final plasmid was named pCH25. Plasmid maps are illustrated in Figure 50. 
 
 
 
   
 
 
 
 
 
The plasmids have a spectinomycin resistance cassette in the opposite orientation 
of the target gene. The final constructs were confirmed by PCR and sequence analysis. 
The relA inducible plasmid, pCH5 was electroporated into 35000HP, 35000HP∆relA and 
35000HP∆relA∆spoT and the resulting strains were designated 35000HP(pCH5), 
35000HP∆relA(pCH5) and 35000HP∆relA∆spoT(pCH5). pCH25, the dksA inducible 
plasmid, was electroporated into 35000HP and 35000HP∆dksA and the final strains 
designated 35000HP(pCH25) and 35000HP∆dksA(pCH25). As controls, 35000HP, 
35000HP∆relA∆spoT, and 35000HP∆dksA were also electroporated with pDG10; the 
resulting strains were designated as 35000HP(pDG10), 35000HP ΔrelAΔspoT(pDG10), 
and 35000HP∆dksA(pDG10).  
Figure 50. Plasmid maps for inducible expression of relA and dksA.  
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Table 11.  Plasmids and primers used for generation of inducible strains 
Plasmids Description Source or reference 
pT A pLS88 derivative 
containing the tetracycline 
(tet) controlled expression 
system 
(204)  
pDG10 pT derivative containing the 
specR resistance cassette 
from pSPECR 
(89)  
pCH5 pT derivative containing the 
relA  ORF 
This Study  
pCH25 pT derivative containing the 
dksA  ORF 
This Study  
    
Primers Purpose Gene 5' to 3' Sequence 
11-P1 For Construction of pCH5 relA ORF F ATATATCCATGGTTAG
TTTGCTAGCCGTTTTG 
11-P2 For Construction of pCH5 relA ORF R ATATATCCATGGATGG
TTGCAATACGTCGTTC 
11-P3 For Construction of pCH25 dksA ORF F ATATATCCATGGATGG
TTCAAGTGGCAACTAC 
11-P4 For Construction of pCH25 dksA ORF R ATATATCCATGGCTAA
AGCCCCATTTGTTTCT 
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 We next confirmed that pCH5 would induce expression of relA in the relA spoT 
mutant. We grew 35000HP∆relA∆spoT(pDG10) and 35000HP∆relA∆spoT(pCH5) to 
mid-log phase. relA expression was then induced by addition of 200 ng/μl 
anhydrotetracycyline, RNA was harvested at 0, 30, 60, 120, 180, and 240 mins after 
induction. Analysis showed that relA expression was induced after induction with 
anhydrotetracycline and that maximal expression occurred within 30 mins (Figure 51). 
As incubation progresses, induction of relA begins to decrease; the reason for this is 
unclear. Importantly, relA transcripts are expressed prior to induction indicating that the 
pCH5 was still leaky.  
 
 
 
 
Figure 51. Validation of pCH5 plasmid induction of relA. Transcripts levels of relA were 
normalized to that of dnaE. The data represent the means ± SD of the results of three 
independent experiments. 
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SpoT is an essential gene in E. coli because unchecked accumulation of (p)ppGpp 
is often toxic. Therefore, overexpression of relA – and increased accumulation of 
(p)ppGpp – through the inducible system might prove lethal to H. ducreyi. We performed 
growth curves to determine if induction of relA inhibited growth of the relA or relA spoT 
mutant. The pCH5 containing strains and the controls were grown until they reached an 
OD660 of approximately 0.2. Anhydrotetracycyline was added to the cultures and the 
strains were monitored for an additional 4 hours. Presence of pCH5 alone did not inhibit 
growth compared to the empty pDG10 vector (Figure 52). Furthermore, induction of relA 
did not inhibit growth of these strains in this limited time frame (Figure 52). 
 
 
 
 
Figure 52. Growth of relA inducible strains. (A) Growth of 35000HP∆relA∆spoT (pDG10) 
and 35000HP∆relA∆spoT (pCH5) before and after induction of relA. The data represent the 
means ± SD of the results of three independent experiments. 
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Given that induction of relA did not inhibit growth of 35000HP, we utilized this 
strain to induce expression of (p)ppGpp in our de novo labeling assay. The assay was 
performed using cells harvested from mid-log phase since mid-log phase expressed only 
minor levels of (p)ppGpp. (p)ppGpp was detected in 35000HP∆relA∆spoT (pCH5) 
(Figure 53, Lanes 3-5). As expected, no expression was seen in the ∆relA∆spoT mutant 
containing the empty pDG10 vector (Figure 53, Lane 1). Therefore, our inducible relA 
system led to accumulation of (p)ppGpp in vitro. As stated previously, the pT vector is 
leaky. To combat this leakiness, pDG10 was constructed with an antibiotic resistance 
cassette in the opposite orientation of the tet inducible promoter. However, (p)ppGpp can 
still be detected in the uninduced pCH5 containing strain (Figure 53, Lane 2). These lead 
us to conclude that the tet inducible system was still leaky; however overexpression of 
(p)ppGpp without expression of spoT was not lethal in these conditions.  
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DksA overexpression is not linked to toxicity in bacteria. We therefore, did not 
expect to see any growth inhibition in the inducible dksA system. Prior to induction, 
expression of pCH25 alone did not inhibit growth compared to the empty pDG10 vector 
(Figure 54}. However, addition of anhydrotetracycline affected growth of all four strains. 
While the pT and uninduced pCH25 containing strains recovered, the induced pCH25 
containing strain was severely inhibited (Figure 54). We did not assay dksA transcript 
levels after induction of pCH25; therefore we cannot confirm induction of DksA. 
However, addition of anhydrotetracycline to 35000HP∆dksA(pCH25) did appear to 
inhibit growth. 
 
Figure 53. (p)ppGpp expression is 
induced by pCH5 in the absence of 
nutrient limitation. Bacteria were 
labeled with KH232PO4 in phosphate-
limited RPMI plus 5% FBS. 
(p)ppGpp was extracted and detected 
by polyethylenimine cellulose thin 
layer chromatography and 
autoradiography. Lane 1, 
35000HP∆relA∆spoT (pDG10); 
Lanes 2-5 35000HP∆relA∆spoT 
(pCH5): uninduced (2) and induced 
after 30 minutes (3),  1 hour (4), and 
2 hours (5). Blot is representative of 
two independent experiments. 
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In conclusion, we constructed inducible relA and dksA plasmids, pCH5 and 
pCH25, respectively. We showed that pCH5 could be used to induce expression of 
(p)ppGpp in the absence of any in vitro stringent response trigger. Overexpression of relA 
and induced accumulation of (p)ppGpp did not cause toxicity in the ∆relA∆spoT mutant. 
This is surprising, as this strain should be incapable of hydrolyzing any accumulated 
(p)ppGpp; however, our incubation time may be too short to prove lethal Additionally, 
our liquid medium is rich and may counteract the effects of (p)ppGpp accumulation in the 
absence of hydrolase activity as the growth of the pCH5 containing strains was not 
inhibited in vitro (Figure 52).  Our inducible system, therefore, may provide a mechanism 
for studying a hydrolase negative - spoT null - H. ducreyi strain without the necessity of a 
spoT deletion mutant. 
  
Figure 54. Growth of dksA inducible strains. (A) Growth of 35000HP∆dksA (pDG10) and 
35000HP∆dksA (pCH25) before and after induction of dksA. The data represent the means ± 
SD of the results of three independent experiments. 
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